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The utility of fluorine in medicinal and manufacturing chemistry is undisputed. Despite 
its usefulness, the incorporation of fluorine in organic molecules is not without challenges. 
Regardless of their electrophilic or nucleophilic nature, most, if not all, fluorinating reagents 
derive from HF. Nucleophilic reagents are less expensive compared with their counterparts, 
and many are not commercially available. The Hammond laboratory is interested in developing 
and applying HF-based fluorination reagents that are cost effective and capable of enhancing 
both classical and metal based transformations. The following chapters describe some of the 
applications of our HF-based reagent. 
Chapter 2 discusses the preparation and role of DMPU-HF in the fluorination of 
alkynes in the presence of a metal catalyst. This reaction employs the imidogold 
precatalyst, which is activated by DMPU-HF to enhance both mono- and di-fluorination of 
alkynes. Approaches to induce monofluorination and difluorination of terminal alkynes by 
an HF-based reagent, unprecedented in the literature, are also discussed.  
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In Chapter 3, we describe further the application of DMPU-HF to the 
diastereoselective synthesis of fluorinated tetrahydropyrans and the N-tosylpiperidine 
analogues. We also showed that the acidic behavior of DMPU-HF makes it a better 
fluorinating reagent when compared to existing HF-based reagents in these types of 
transformations. 
Further extension of DMPU-HF to the ring opening of aziridines is discussed in 
Chapter 4. A wide variety of N-tosyl aziridines undergo efficient ring opening in the 
presence of DMPU-HF at room temperature. The methodology was also extended to some 
N-substituted aziridines including unactivated substrates, all of which were efficiently 
fluorinated under these conditions. 
Chapter 5 gives an overview of some of the applications of DMPU-HF to other 
known C-F bond formations. Examples of such transformations include but are not limited 
to the ring opening of epoxides, fluorobromination of unsaturated compounds and the metal 
free synthesis of fluoroamines.  
Finally, Chapter 6 provides spectroscopic data for all the new compounds prepared 






TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ........................................................................................................... III 
ABSTRACT .................................................................................................................................... V 
LIST OF SCHEMES...................................................................................................................... IX 
LIST OF TABLES .......................................................................................................................... X 
LIST OF EQUATIONS ................................................................................................................. XI 
LIST OF FIGURES ..................................................................................................................... XII 
1 INTRODUCTION ........................................................................................................ 1 
1.1 The History and Importance of Organofluorine Chemistry ......................................... 1 
1.2 Properties of fluorine .................................................................................................... 3 
1.2.1 Electronic effect of fluorine ..................................................................................... 3 
1.2.2 Bond energy and bond length .................................................................................. 4 
1.2.3 Size of fluorine ......................................................................................................... 4 
1.3 Fluorination in organic chemistry ................................................................................ 6 
1.4 The hydrogen bonding concept and the development of new HF-based reagent-
DMPU-HF. ................................................................................................................. 13 
1.5 Summary of thesis research ........................................................................................ 17 
2 DESIGNER HF-BASED NUCLEOPHILIC REAGENTS: HIGHLY 
REGIOSELECTIVE SYNTHESIS OF FLUOROALKENES AND GEM-
DIFLUOROMETHYLENE COMPOUNDS FROM ALKYNES ................................................. 18 
2.1 Preparation of designer HF-based nucleophilic reagents ........................................... 18 
2.2 Monofluorination of alkynes using DMPU-HF.................................................... 19 
2.3 Gem-difluorination of alkynes using DMPU-HF ....................................................... 23 
2.4 Conclusion .................................................................................................................. 27 
2.5 Experimental section .................................................................................................. 27 
3 PREPARATION OF FLUORINATED TETRAHYDROPYRANS AND 
PIPERIDINES USING A NEW NUCLEOPHILIC FLUORINATION REAGENT–DMPU-HF 37 
3.1 Background ................................................................................................................ 37 
3.2 Fluoro-Prins cyclization reaction ............................................................................... 38 
3.3 Fluoro-Prins reaction with DMPU-HF ....................................................................... 39 
3.4 Aza-Prins fluorination reaction .................................................................................. 42 
viii 
 
3.5 Mechanism and stereochemistry of fluoro-Prins cyclization reaction ....................... 44 
3.6 Summary .................................................................................................................... 47 
3.7 Experimental section .................................................................................................. 48 
4 REGIOSELECTIVE RING OPENING OF AZIRIDINES BY DMPU-HF .............. 57 
4.1 Background ................................................................................................................ 57 
4.2 Results and discussions .............................................................................................. 60 
4.3 Regiochemistry of products ........................................................................................ 66 
4.4 Experimental .............................................................................................................. 67 
4.5 Conclusion .................................................................................................................. 93 
4.5.1 Crystal data and structure refinement for (S)-4-1d. ............................................... 93 
4.5.2 Crystal data and structure refinement for (S)-4-2d. ............................................. 101 
5 OTHER NUCLEOPHILIC REACTIONS BY DMPU-HF ...................................... 110 
5.1 Introduction .............................................................................................................. 110 
5.2 Bromofluorination of unsaturated compounds ......................................................... 110 
5.3 Ring opening of epoxides ......................................................................................... 113 
5.4 Metal free dual functionalization of alkenes ............................................................ 116 
5.5 Summary and conclusions ........................................................................................ 120 
5.6 Experimental ............................................................................................................ 120 
6 SPECTROSCOPIC DATA ...................................................................................... 130 
REFERENCES ............................................................................................................................ 257 
APPENDIX .................................................................................................................................. 272 








LIST OF SCHEMES 
Scheme 1. Preparation of 9α-fluorocortisol. ....................................................................... 9 
Scheme 2. Synthesis of 1-fluoro-2,3,4,6-tetra-O-benzyl-1-deoxy-α-D-glucose using 
Olah’s reagent. .................................................................................................................. 10 
Scheme 3. Fluorination by TBAF generated in situ. ........................................................ 12 
Scheme 4. Enantioselective synthesis of fluorohydrins by HF generated in situ. ............ 12 
Scheme 5. Comparing hydrogen bond dissociation and a Brønsted acid-base reaction. .. 13 
Scheme 6. Selectivity of DMPU-HF/Au-1 fluorination system. ...................................... 23 
Scheme 7. Synthesis of fluorocarbocycles. ....................................................................... 27 
Scheme 8: General case for the Prins reaction. ................................................................. 37 
Scheme 9. Example of the condensation reaction carried out by H.J Prins in 1919. ....... 38 
Scheme 10. Prins cyclizattion leading to the fluorinated pyran. ....................................... 38 
Scheme 11. Reactivity and selectivity of Olah’s reagent and DMPU-HF on fluoro-Prins 
reaction. ............................................................................................................................. 41 
Scheme 12. Weinreb’s example of aza-Prins cyclization reaction. .................................. 43 
Scheme 13. Proposed mechanism for the fluoro-Prins cyclization. ................................. 45 
Scheme 14. Plausible stereochemical outcome for the Prins cyclization ......................... 46 
Scheme 15. Synthetic routes toward β-fluoroamines. ...................................................... 58 
Scheme 16. Scope of N-tosylaziridines ............................................................................ 62 
Scheme 17. Stereospecific ring opening of aziridine (S)-4-4d by HF. ............................. 64 
Scheme 18. Bromofluorination of alkenes...................................................................... 111 
Scheme 19. Preliminary results of bromofluorination of alkenes with DMPU-HF. ...... 112 
Scheme 20. Bromofluorination of phenylbutyne with DMPU-HF and a brominating 
source. ............................................................................................................................. 113 






LIST OF TABLES 
Table 1. pKa of organic acids in comparison to their fluorinated analogue. ....................... 3 
Table 2. pKb of organic bases in comparison to their fluorinated analogue. ...................... 4 
Table 3. Bond strength of R-X (Kcal/mol). ........................................................................ 4 
Table 4. Selected reactions with Olah’s reagent. .............................................................. 10 
Table 5. Reaction condition optimization of mono-hydrofluorination of alkyne. ............ 20 
Table 6. Substrate scope for monofluorination of alkyne. ................................................ 22 
Table 7. Optimization for di-hydrofluorination of alkyne 1. ............................................ 25 
Table 8. Substrate scope for di-hydrofluorination of alkyne 2-1. ..................................... 26 
Table 9. Optimization of the fluoro-Prins reaction. .......................................................... 40 
Table 10. Scope of the fluoro-Prins reaction. ................................................................... 42 
Table 11. Scope of the aza-Prins fluorocyclization. ......................................................... 44 
Table 12. Development of reaction conditions. ................................................................ 61 
Table 13. Scope of N-protected groups. ........................................................................... 63 
Table 14. Bromofluorination of allylic alkenes. ............................................................. 112 
Table 15. Regioselectivity of epoxide ring opening by amine—HF reagents. ............... 114 
Table 16. Ring opening of epoxides using DMPU-HF................................................... 115 
Table 17. Optimization studies on the direct aminofluorination of alkenes. .................. 119 







LIST OF EQUATIONS 
Equation 1. Control experiment on the role of Lewis acid on gem-difluoro synthesis. ... 26 







LIST OF FIGURES 
Figure 1. Some fluorinated metabolite products and their sources. .................................... 2 
Figure 2. Fluorine as a mimic for hydrogen in bioactive molecules. ................................. 5 
Figure 3. Alternatives to dialkyaminosulfur trifluorides. ................................................... 7 
Figure 4. Lack of general relationship between pKBHX and pKBH+ ................................... 16 
Figure 5. Comparison of DMPU-HF with pyridine-HF and Et3N-HF ............................. 16 
Figure 6. Schematic representation of the pKBHX scale of common organic compounds. 19 
Figure 7. Examples of medicines containing difluoromethylene (CF2). .......................... 24 
Figure 8. β-Fluoroamines in medicinal chemistry. ........................................................... 57 
Figure 9. Representative spectrum of the regioisomeric distribution of 4-2a using 19F 
NMR ................................................................................................................................. 67 






This chapter provides a brief overview of fluorine containing compounds and also 
surveys some existing methods for nucleophilic fluorination. Also, in this chapter, a 
literature precedent for the use of common HF-based reagents like pyridine-HF (Olah’s) 
and trimethylamine trishydrogen fluoride will be discussed. More importantly, the 
hydrogen bond basicity concept and the introduction of DMPU-HF will be examined. 
1.1 The History and Importance of Organofluorine Chemistry 
Fluorine is the 13th most abundant element on earth, yet despite this fact, naturally 
existing organofluorine compounds are scarce, with just about 21 fluorinated secondary 
metabolites identified to date. Eight out of these metabolites are isolated from the plant 
Dichapetalum toxicatium and they are ω-fluorinated fatty acids (Figure 1).1 Compared to 
other halogens like chlorine, iodine or bromine, which in many instances occur in natural 
products (ca. 3000), we see a huge disparity with that of fluorine containing natural 
products. This disparity can be attributed to two major factors: first, fluorspar (CaF2), 
which is the most abundant form of natural occurring fluorine, has a very low solubility in 




Figure 1. Some fluorinated metabolite products and their sources. 
Fluorine element, since its discovery in 1886 by Henri Moissan, has played a 
prominent role in the scientific community because of its peculiar properties.3 The presence 
of one or more fluorine atom(s) in an organic compound endows reactivity and properties, 
which are significantly different from those of its non-fluorinated analogue without 
enormous modification of sterics.4 Today, fluorine containing compounds have been 
applied in various fields such as medicine,5 agrochemicals,6 electronics and organic 
materials.7 It is not surprising therefore that the study of fluorinated organic materials 
currently constitutes a field of research, which has seen tremendous progress in recent 
years, as demonstrated by the increase in publications of fluorine containing compounds.8 
This significant growth can be attributed to the unique reactivity observed in compounds, 
which have the fluorine atom.  
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1.2 Properties of fluorine 
As earlier posited, one or more fluorine atoms in an organic molecule confers 
significant changes to its properties. These significant changes are due to the unique 
properties of the fluorine atom and some of these properties are discussed as follows. 
1.2.1 Electronic effect of fluorine 
 Fluorine element has a value of 4.0 in the Pauling electronegativity scale,9 thus 
making it the most electronegative element known. The strong electronegativity of the 
fluorine element gives it a powerful negative inductive (–I) ability, which usually has 
dramatic effects on the acidity or basicity of neighboring functional groups10 (Table 1). This 
fact has been exploited to enhance the bioavailability or binding affinity of pharmaceutical 
drugs.5b 
For instance, the pKa as reported in Table 13 of a series of organic acid decreases 
when fluorine is substituted for hydrogen due to its strong inductive effect. Also the 
basicity of organic bases decreases after fluorination as illustrated in Table 2.3 
Table 1. pKa of organic acids in comparison to their fluorinated analogue. 
Acid pKa 
 
Acid (F) pKa 
CH3COOH 4.76 CF3COOH 0.52 
C6H5COOH 4.21 C6F5COOH 1.75 
CH3CH2OH 15.9 CF3CH2OH 12.4 




Table 2. pKb of organic bases in comparison to their fluorinated analogue. 
Base pKb Bases (F) pKb 
 
CH3CH2NH2 3.3 CF3CH2NH2 8.1 
C6H5NH2 9.4 C6F5NH2 14.4 
 
1.2.2 Bond energy and bond length 
The carbon-fluorine (C-F) bond is the strongest of the carbon/other element bonds. 
This bond strength plays a huge role in determining much of the chemistry of 
organofluorine compounds. For instance, the C-F bond strength is much greater than that 
of the other halogen atoms (Table 3). The implication of this is that while alkyl bromides 
or iodides readily undergo SN1 and/or SN2 reactions, alkyl fluorides are much less reactive.
3 
As a matter of fact, the reactions of alkyl fluorides with strong nucleophiles proceed via 
elimination (E2) rather than via nucleophilic substitution. 
Table 3. Bond strength of R-X (Kcal/mol). 
R 
 
H F Cl Br I 
CH3 105 113 84 70 57 
CH3CH2 101 111 85 71 56 
 
1.2.3 Size of fluorine 
 The Van der Waals radius of fluorine is 1.47 Å, in contrast to hydrogen, which is 
1.20 Å, making fluorine the smallest element after hydrogen. Fluorine though closer in size 
to oxygen (1.57 Å),11 has been found to be a good substitute for hydrogen, which in most 
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cases results to a useful steric bias.12 Fluorine, due to its steric resemblance with hydrogen, 
has been successfully employed to mimic hydrogen in bioactive molecules.13 It should be 
noted however, that despite this steric resemblance, the high electronegativity of fluorine 
relative to hydrogen renders both the reactivity and polarity of the C-F bond orthogonal to 
that of the C-H bond. This fact has also been thoroughly explored in the design of 
fluorinated drugs like the fluorinated thalidomide or fluorouracil (Figure 2).  
 
Figure 2. Fluorine as a mimic for hydrogen in bioactive molecules. 
More so, due to the similarity in size between fluorine and oxygen as well as their 
similar electronegativity (3.98 and 3.44 on the Pauline scale), fluorine, when replaced with 
oxygen, has been employed in probing the importance of hydrogen bonding versus bond 
polarity in biological systems.14 The replacement of a C-OH to a C-F bond though 
accompanied by the loss of the acidic hydrogen has helped in understanding the role of the 
C-OH bond in biological systems, especially with respect to its polar nature and its 
hydrogen bonding properties. Unlike the C-OH bond, replacement of a C=O group with a 
C-F or a CF2 group is not ideal requiring significant changes to the geometry at carbon 
(from sp2 to sp3), which also involves an unsatisfactory change in molecular shape.  
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1.3 Fluorination in organic chemistry 
 The role of fluorine is not limited to the modification of the molecular properties 
of organic molecules or pharmaceutical compounds. The 19F nucleus, for instance, has an 
excellent NMR profile and has become a popular choice with chemical biologists, for the 
investigation of macromolecules as well as the study of metabolic processes. More so, 19F 
NMR has also been applied in the growing field of positron emission topography (PET)), 
which is an imaging technique used in clinical diagnosis. PET utilizes the short lived 18F 
fluorine isotope.15 Fluorination in organic chemistry can therefore be achieved either by 
electrophilic or nucleophilic fluorinating reagents.  
Electrophilic fluorination involves the utilization of an “F+” reagent that is attacked 
by electron rich centers. Thus, reagents that are able to transfer “F+” to an electron rich site 
are considered electrophilic reagents. Elemental fluorine is such a reagent, but due to its 
high reactivity, low selectivity and toxicity, its use is limited.16 Over the years, a large 
number of “F+” reagents have been developed, which have been used extensively for the 
fluorination and discovery of organic molecules. Such reagents include but are not limited 
to RO-F (e.g, fluoroxytrifluoromethane),17 N-F (e.g, N-fluoropyridinium triflates, 
Selectfluor and their derivatives).18 
Nucleophilic fluorination is another useful strategy in achieving fluorination of 
organic compounds. This primarily involves the use of fluoride ion, such as fluoride salts 
like KF or reagents that are capable of releasing fluoride ion. One big challenge to the use 
of the fluoride ion as a fluorinating source is its ability to be strongly solvated in protic 
solvents, which makes it a poor nucleophile. Also, it forms a tight ion pair in most aprotic 
solvents, limiting its nucleophilic profile. In order to increase its nucleophilic properties, 
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these barriers need to be overcome. Considerable efforts have been made in developing 
nucleophilic fluorinating reagents in the last decades. For example, in 1975, Middleton19 
reported the preparation of diethylaminosulfur trifluoride (DAST), which could substitute 
a hydroxyl and/or carbonyl oxygen with fluorine to generate the mono and/or gem-
difluoronated products respectively.20 One drawback of DAST is that it undergoes 
explosive degradation at temperatures above 90 ◦C. Several other dialkyaminosulfur 
trifluoride analogues have since been developed with similar reaction mechanism. Among 
these reagents are perfluoro-1-butanesulfonyl chloride 1-9 (PBSF),21 the commercially 
available tetrafluoroethyldimethylamine 1-10 (TFEDMA),22 the Ishikawa reagent23 1-11 
and Fluolead24 1-12, which was introduced in 2009 by Umemoto (Figure 3).  
 
 
Figure 3. Alternatives to dialkyaminosulfur trifluorides. 
HF-based reagents  
 In 1771, Wilhelm Scheele liberated hydrogen fluoride from the mineral fluorspar 
(CaF2) using sulfuric acid and noted that the acid so formed, destroyed glass.
25 Later in the 
19th century, Sir Humphrey Davy determined that this acid did not contain oxygen. While 
trying to understand hydrogen fluoride, many scientists were badly injured or died. For 
example, Sir Davy lost his eyes, Gay-Lussac and Henri Moissan and many others died 
during the course of their work with hydrogen fluoride.26 Hydrogen fluoride is one of the 
most inexpensive sources of fluoride but its use is very limited because of its corrosiveness, 
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toxicity and low boiling point (b.p 19 ◦C). Its handling requires special apparatus. 
Anhydrous hydrogen fluoride is used as an alkylation catalyst in gasoline production and 
has also been applied in aluminum production, steel treatment, glass etching, and 
refrigeration manufacture of fluorocarbons as well as semiconductors.27 
Although HF is diatomic, the HF molecules in anhydrous hydrogen fluoride (AHF) 
form relatively strong intermolecular H…F hydrogen bonds. It is noteworthy that AHF is 
more commonly used than the aqueous hydrogen fluoride. This is because AHF is miscible 
with water in any proportion due to the high solvation properties of fluoride ion.28 Aqueous 
hydrogen fluoride is a very weak acid, as well as a weak nucleophile. Turrell and co-
workers using vibrational spectroscopy described the apparent weakness of aqueous HF as 
due to a strong ion pair or proton transfer between water molecules and the fluoride ion.29 
Aqueous HF is much easy to handle than AHF, but too weak to induce fluorination as 
compared to AHF. Anhydrous fluoride has been applied in halogen exchange reactions,30 
and has been applied as a solvent and catalyst in Friedel-Craft reactions. In this case, it 
usually promotes unselective reactivity, such as acid mediated rearrangements and 
polymerization.31  
Despite the unwanted side reactions and toxicity of AHF, Fried and Sabo in 1954, 
demonstrated a major reactivity of AHF when the fluorinated derivative of cortisone was 
prepared. Their studies spurred a revolution in the study of synthetic steroids and 
essentially medicinal chemistry.32 As an example, 9α-fluorocortisol (brand name Florinef) 
is found to possess ten times the biological activity of cortisol, which according to Fried is 




Scheme 1. Preparation of 9α-fluorocortisol. 
Another revolution was observed when Hirschmann and coworkers reported that 
under the same conditions they were unable to reproduce the result of Fried and Sabo in 
the preparation of fluorocortisol. However, they reported that the addition of a base like 
pyridine, tetrahydrofuran or ammonia to the AHF/chloroform mixture led to an appreciable 
yield of the fluoricortisol acetate.33 They anticipated that by controlling the amount of 
pyridine or any other organic bases in the AHF/base mixture, they could influence the 
reactivity of AHF in the synthesis of fluorocortisol.  
Bergstrom and coworkers, following the lead from the results of Hirschmann on 
the synthesis of 9α-fluorocortisol, prepared a 70% solution of HF in Pyridine 
(Pyridine.9HF) for the hydrofluorination of dehydrosteroids to form 9α-fluoro-11-
deoxysteroids.34 Few years later, Olah and co-workers explored the synthetic utility of 
Pyridine/HF mixture and came up with interesting findings of its applicability. No wonder 
the reagent is being regarded today as Olah’s reagent or pyridinium 
poly(hydrogenfluoride) (PPHF).35 
The laboratory of Olah demonstrated the reactivity of PPHF on a wide range of 
organic substrates and reactions, which include but are not limited to alkynes, alcohols, 
alkenes and the ring opening of epoxides. Representative examples of the reactivity of 
PPHF as demonstrated by Olah’s laboratory are highlighted in Table 4.  
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Table 4. Selected reactions with Olah’s reagent. 
 
  
Perhaps one of the more notable applications of PPHF is the fluorination of the 
anomeric position in carbohydrates36 described by Noyori and coworkers in the preparation 
of glycosyl fluorides Scheme 2. The authors concluded that amidst the available 
fluorination reagents and methods for the synthesis of fluorinated carbohydrates, the 
attractiveness of PPHF (Olah’s reagent) is characterized by its wider applicability, high 
yield, operational simplicity and the low cost. 
 




From these results, PPHF is believed to have superior chemoselectivity to AHF in 
many cases and before now, it was considered to be highly acidic for which all reactions 
must be carried out in plastic vessels. So, by varying the nature of the Lewis base and the 
stoichiometry of HF relative to the base, chemists essentially developed a variety of HF-
base reagents with a range of properties.37 The more common base being used other than 
pyridine is triethylamine, which has since led to the much milder nucleophilic fluorinating 
source TREAT-HF or triethylamine trifluoride (Et3N.3HF). One very important advantage 
of TREAT-HF, is the fact that it can be used in standard glass vessels and distilled in vacuo 
without the release of HF, albeit the use of TREAT-HF requires more forcing conditions.38 
Latent hydrogen fluoride source 
In situ generated fluoride ion for nucleophilic reactions was introduced recently as 
a useful strategy to combat the many problems associated with fluoride ions, which ranges 
from the ease of solvation in protic solvents, insolubility in organic solvents (e.g fluoride 
salts like CsF), toxicity and handling difficulties (e.g, AHF). In 2005, DiMagno and Sun 
reported that anhydrous tetrabutylammonium fluoride (TBAF) can be generated in situ by 
the low temperature reaction of hexafluorobenzene and tetrabutylammonium cyanide, and 
that the resulting reagent is stable at room temperature.39 TBAF prepared from this in situ 
protocol was efficiently applied in the fluorination of simple alkyl halides and sulfonates 
at room temperature without forming the hydrolysis byproducts, which are typical of 




Scheme 3. Fluorination by TBAF generated in situ. 
Inspired by this work, the Doyle group envisioned that they could enhance 
asymmetric fluorination by using latent HF source. Such latent HF would comprise a 
source of fluoride and a source of proton. They believed that this strategy will circumvent 
the handling issues associated with HF-containing reagents. So in 2010, the Doyle group 
demonstrated the dual cooperative catalytic enantioselective ring opening of epoxide by 
latent HF. The latent HF was formed in situ by the catalytic action of 1,5-
diazobiclo[4.3.0]non-5-ene (DBN) or tetramisole on benzoylfluoride and 1,1,1,3,3,3-
hexafluoroisopropanol (HFIP).40  
 
Scheme 4. Enantioselective synthesis of fluorohydrins by HF generated in situ. 
A follow up of their protocol demonstrated its effectiveness in the ring opening of 
aziridines41 as well as the enantioselective catalytic ring opening of aziridines.42 While this 
method is attractive, it is neither cost effective nor atom economical, which could limit its 
general applicability especially for scale-up processes.  
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1.4 The hydrogen bonding concept and the development of new HF-
based reagent-DMPU-HF.  
Most, if not all, fluorinating reagents (electrophilic or nucleophilic) are made from 
hydrogen fluoride (HF). Therefore, an HF-based fluorinating reagent would be ideal in 
terms of cost and atom economy, but HF itself is a hazardous gas at room temperature and 
is very difficult to handle without special equipment as stated earlier. The only existing 
complexes of HF with organic bases are: pyridine-HF (Olah’s reagent)37, 43 and 
triethylamine-HF.44 These are liquids at room temperature and have been explored 
extensively as nucleophilic sources of fluorine,37 but their use is hampered by the fact that 
the organic bases (pyridine and trimethylamine) reduce the acidity of the system and may 
interfere with many metal catalysts. For example, pyridine can complex strongly with 
many transition metals and therefore reduce their activities. In general, pyridine-HF and 
triethylamine-HF are not ideal reagents for acids or metal catalyzed reactions. If HF-based 
nucleophilic fluorination reagents could be made compatible with acid or transition metal 
catalysts, it could open the door for reactivities and selectivities hitherto unknown. Our 
primary goal is to develop a new generation of HF-based nucleophilic fluorination reagents 
to overcome the existing drawbacks with pyridine-HF and triethylamine-HF, namely 
incompatibility with acids or transition metal catalysts.  
 
Scheme 5. Comparing hydrogen bond dissociation and a Brønsted acid-base reaction. 
When an organic base (e.g., pyridine) interacts with HF (an acid), it serves 
simultaneously as a hydrogen bond acceptor (HBA) and a Brønsted base (Scheme 5) 
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Hydrogen bonding, rather than an ionic interaction, has been identified to be the major type 
of interaction between HF and an organic base in complexes like pyridine-HF.37 In order 
to reduce the volatility of an HF complex (make it a liquid or solid at room temperature), 
we have to use a relatively good hydrogen bonding acceptor (HBA) to complex with HF. 
Our hypothesis is that a strong (good) hydrogen bonding acceptor is not necessarily a 
strong base (Brønsted or Lewis base). Thus, a compound that serves as good hydrogen 
bonding acceptor (better than pyridine or triethylamine), while being less basic (e.g., less 
basic than pyridine) is expected to form a less volatile complex. And due to the low basicity 
of this HBA, the HBA-HF complex will be compatible with acid catalysts or mediators. 
By doing this, we may achieve unprecedented reactivity and selectivity in HF-participating 
reactions. In order to accomplish this goal, it is foremost necessary to investigate a 
quantitative descriptor of hydrogen bond basicity and Brønsted basicity. Because there is 
no unified Lewis basicity scale, we focused on Brønsted basicity first.  
It is commonly assumed that the relative hydrogen-bond basicity of an organic 
compound bears a simple correlation with its Brønsted basicity (pKaH
+, pKa of its conjugate 
acid); however, this assumption holds true only for structurally close related compounds 
(Figure 4). In 2009, Laurence and co-workers reported a comprehensive database of 
hydrogen-bond basicity (measured by pKBHX).
45 The pKBHX of most compounds ranges 
from 1 to 5, where a bigger number indicates a more stable hydrogen bond complex.45 
Based on analytical results of 232 typical nitrogen, oxygen, sulfur and carbon bases, there 
was no general relationship between pKBHX and pKaH
+ (Figure 4).45 In other words, a weak 
base is not necessarily a weak hydrogen bond acceptor. This finding will allow us to 
15 
 
discover new good hydrogen bonding acceptors, which are weak bases themselves but 
capable of complexing with HF. 
From figure 4, we see that both pyridine and triethylamine are considered as 
‘ordinary bases’, since they are close to the trend (solid yellow line in Figure 4). We seek 
‘anomaly’ HBAs, that is, good hydrogen bond acceptors that are also weak Brønsted bases. 
Among many ‘anomaly’ hydrogen bond acceptors in the Laurence’s database, 1,3-
dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU) is one we thought of as a 
potential candidate. DMPU (pKBHX = 2.82) is a much better hydrogen bond acceptor 
than pyridine (pKBHX = 1.86) and Et3N (pKBHX = 1.98),
45 and at same time it is 
significantly less basic than pyridine and Et3N (Figure 5). Thus, a DMPU-HF 
solution should have a higher complex ratio compared to pyridine-HF or 
triethylamine-HF complexes. In addition, DMPU only weakly coordinates to most 
transition metal catalysts, so DMPU is less likely to interfere with most transition metal 
catalysts. Moreover, DMPU is a very weak nucleophile, so it will not compete with 
HF in nucleophilic reactions. In addition, it has other advantages such as low cost, 
wide availability, environmental friendliness, and chemical inertness, compared to 
several competitors, such as hexamethylphosphoramide (HMPA) and 
tris(pyrrolidinophosphine) oxide. Therefore, the DMPU-HF complex would be an 
ideal new fluorination reagent,46 especially in transformations mediated by acids or 




Figure 4. Lack of general relationship between pKBHX and pKBH+ 
 
 






















































1.5 Summary of thesis research 
The Hammond laboratory is interested in developing an HF-based nucleophilic 
fluorination reagent that are cost effective and are capable of enhancing both classical and 
metal based synthetic transformations. The following chapters describe some of the 





2 DESIGNER HF-BASED NUCLEOPHILIC REAGENTS: 
HIGHLY REGIOSELECTIVE SYNTHESIS OF 
FLUOROALKENES AND GEM-DIFLUOROMETHYLENE 
COMPOUNDS FROM ALKYNES 
2.1 Preparation of designer HF-based nucleophilic reagents 
We have established from Figure 4 that a higher pKBHX implies a high tendency of 
a substance to form strong hydrogen bond. The reported comprehensive database of the 
hydrogen-bond basicity of over a thousand compounds (hydrogen bond acceptors 
Figure 6) by Laurence and co-workers45 assisted us as a guide in the preparation of 
suitable bases or solvents for use in our designer HF-based reagents. Among the many 
hydrogen bonding acceptors in Laurence’s database, we considered 1,3-dimethyl-
3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU) as an ideal hydrogen bonding 
acceptor to form a complex with HF. DMPU is inexpensive and is readily available. 
What is even more important, as illustrated in Figure 5, DMPU (pKBHX = 2.82) is a 
better hydrogen bonding acceptor than pyridine (pKBHX = 1.86) and Et3N (pKBHX = 
1.98),45 and at same time DMPU is much less basic than pyridine and Et3N). So, a 
DMPU-HF complex should have higher acidity compared to pyridine-HF and 
triethylamine-HF complexes. Also, DMPU is weakly coordinating to most metal 
catalysts, so DMPU is unlikely to interfere strongly with most transition metal catalysts. 
Moreover, DMPU is a very weak nucleophile, so it will not compete with HF in 
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nucleophilic reactions. Therefore, HF/DMPU complex can be an ideal new 
fluorination reagent, especially in transition metal catalyzed reactions.  
  
Figure 6. Schematic representation of the pKBHX scale of common organic compounds. 
2.2 Monofluorination of alkynes using DMPU-HF 
Fluoroalkenes are important synthetic building blocks and targets,48 but they are 
made from a shallow pool of fluoro-alkene synthons,49 or their preparation requires lengthy 
procedures that are not functional group friendly.50 Typical synthetic methods of 
fluoroalkenes include tandem addition-reduction,50a tandem addition-elimination,51 
Shapiro reaction,48b Julia-Kocienski olefination,52 or Peterson olefination.53 Sadighi and 
coworkers have reported a SIPr-Au catalyzed mono-hydrofluorination of alkynes using 
Et3N/HF complex,
54_ENREF_58 but due to the low acidity of the Et3N/HF system 
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stoichiometric amounts of acid and acidic co-catalyst have to be used. Also, this method 
only works for internal alkynes, where there is no reliable way to control regioselectivity. 
By taking advantage of the unique properties of our DMPU-HF reagent, we were able 
to mono- and di-hydrofluorinate both, terminal and internal alkynes in highly 
regioselective fashion.  
Table 5. Reaction condition optimization of mono-hydrofluorination of alkyne. 
 
Entry HF sourcea catalyst time / h 2a / %b 3a / % 
1 Pyridine/HF - 24 0 0 
2 Bu4N
+OTf-/HF - 48 0 0 
3 DMPU-HF - 48 0 0 
4 Pyridine/HF TfOH (100%) 24 0 0 
5 DMPU-HF TfOH (100%) 24 0 0 
6 Pyridine/HF Au-1 (5%) 5 13 3 
7 DMPU-HF Au-1 (5%) 5 48 52 
































a) Concentration of HF sources: pyridine/HF (70%), DMPU-HF (65 w/w %), b) determined by GC-MS. 
 
We used the mono-hydrofluorination of 2-1a as our model reaction. The 
fluorination agents alone were not able to fluorinate alkyne 2-1a (Table 5, entries 1-3) and 
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a strong acid (TfOH) was not an effective mediator either (Table 5, entries 4-5). The 
HF/DMPU complex we prepared has 65 w/w% HF content, mole ratio of HF:DMPU 
is around 11.8:1. Recently, we reported an acid-assisted activation of an imidogold 
precatalyst as a superior way to generate cationic gold compared to the common silver 
based methodology.55 We found that our DMPU-HF system is acidic enough to activate the 
imidogold precatalyst (Au-1). Indeed, the DMPU-HF system is much more efficient in the 
fluorination of 2-1a (Table 5, entries 6-7) than the commonly used pyridine/HF. DMPU-
HF/Au-1 system is highly reactive but it gave a mixture of mono-fluorinated product 2-2a 
and di-fluorinated product 2-3a (Table 5, entry 8). We were able to achieve a selective 
mono-fluorination by reducing the amount of fluorination reagent from 3 equiv to 1.2 equiv 
(Table 5, entry 9). We were able to maintain the good yield and selectivity of product 2-2a 
even at lower gold pre-catalyst loading (2% and 1%) (Table 5, entries 10-11, respectively).  
With optimized conditions in hand, we investigated the scope of the mono-
hydrofluorination of alkynes (Table 6). Clean and regioselective transformations were 
observed for all the terminal alkynes tested (Table 6, entries 1-8). The reaction also worked 
well for internal alkynes though longer reaction times and higher loadings of gold catalyst 
were needed (Table 6, entries 9-11). This reaction also has good functional group tolerance: 
an alkyne with a strong electron withdrawing group (Table 6, entry 9) and an alkyne with 
an acidic C-H and ester groups (Table 6, entry 12) gave the corresponding fluoro-alkenes 
in good yields and selectivity.  
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We found that in the mono-hydrofluorination of an acceptor substituted terminal 
alkyne 2-1m, the DMPU-HF/Au-1 system yielded a completely different regioisomer 
compared to the literature, when no catalyst was used. Thus, the uncatalyzed HF addition 
to 2-1m gave the Michael addition product 2-5),56 whereas our DMPU-HF/Au-1 system 
reversed the tendency towards Michael addition to give 2-2m instead as the only isomer 
(Scheme 6a). 
The DMPU-HF/Au-1 system is highly effective for alkyne hydrofluorination, but 
it is not a good catalyst for hydrofluorination of alkenes (Scheme 6c). In other words, 
alkene groups are well tolerated. For example, a 1:1 mixture of 1-octene (2-6) and 1-octyne 
(2-1b) gives only alkyne hydrofluorination product 2-2b under the same conditions of our 
model reaction. 
 
Scheme 6. Selectivity of DMPU-HF/Au-1 fluorination system. 
2.3 Gem-difluorination of alkynes using DMPU-HF 
Organic compounds containing a gem-difluoromethylene group are useful for a 
variety of applications in biological, pharmaceutical and materials chemistry. In this 
regard, gem-difluoromethylene-containing compounds have been sought after due to their 
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HIV protease,57 and protein tyrosine phosphatase inhibitions, phosphate,58 carbonyl59 and 
retropeptide60 mimicries. In addition, the anomeric effects of heteroatom substituents such 
as δ-fluorinated ethers, -thioethers and -amines have sparked a flurry of new applications.61 
For example, there are a good number of successful applications of CF2 containing 
compounds in medicine and advanced materials. Examples of the former are shown in 
Figure 7. 
 
Figure 7. Examples of medicines containing difluoromethylene (CF2). 
 Over the years a variety of synthetic protocols for this class of compounds have 
been developed. They can be prepared from their corresponding carbonyl compounds or 
through various derivatives such as oximes and dithiolanes,62 electrophilic fluorinations of 
unsaturated compounds and enolates,63 free-radical additions of halodifluoroalkanes to 
olefins,64 and nucleophilic difluoromethylations of aldehydes and ketones.65 Other 
approaches involve methods that utilize fluorinated compounds as synthons.66 
Enantioselective gem-difluorination reactions have emerged employing chiral auxiliaries 
such as sulfinimines, and chiral Lewis acid catalysts.67 In this regard, the di-
hydrofluorination of an alkyne is a straightforward and atom economic way to synthesize 
CF2 containing compound 2-3. Olah and coworkers have reported the synthesis of the 
difluorinated alkane in limited scope and selectivity.43 As shown above in Table 5, we 
observed the formation of 2-3a during our search for optimal conditions for the synthesis 
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of 2-2a (entry 8). We believed that further hydrofluorination of fluoroalkene 2-2 would 
give di-hydrofluorination product 2-3, but, as we saw in Scheme 6c, our DMPU-HF/Au-1 
system is not a good catalytic system for the hydrofluorination of alkene, so a complete 
conversion of 2-2 to 2-3 is difficult. We then explored the possibility of using a co-catalyst 
or additive that could catalyze further the hydrofluorination of 2-2 to give the desired 
product 2-3 (Table 7). Additional nucleophilic fluorine sources (CsF and AgF, Table 7, 
entries 1-2) were moderately effective, but could not convert all the 2-2a to 2-3a. A weak 
Lewis acid (KCTf3, Table 7, entry 3) was not effective either but stronger acids (Ga(OTf)3 
and KHSO4, Table 7, entries 4-5) helped to produce 2-3a with very good selectivity. 
Because KHSO4 is relatively inexpensive and readily available, we selected KHSO4 as our 
co-catalyst for the synthesis of 2-3.  
Table 7. Optimization for di-hydrofluorination of alkyne 1. 
 
 
We conducted a control experiment to get a clearer understanding of the role of a 
Lewis acid like Ga(OTf)3 in the formation of gem-difluoromethylene compound 2-3 
entry Additive time / h 2-2a / % 2-3a / % 
1 CsF (100%) 24 15 85 
2 AgF (100%) 24 96 4 
3 KCTf3 (10%) 24 67 33 
4 Ga(OTf)3 (10%) 24 <0.5 99 
5 KHSO4 (150%) 24 <1 99 
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(Equation 1). DMPU-HF alone can convert 2-2a to 2-3a without any catalyst, but this 
reaction is sluggish (Equation 1, condition 1). However, a Lewis acid like Ga(OTf)3 can 
significantly speed up this conversion (Equation 1, condition 2). 
 
Equation 1. Control experiment on the role of Lewis acid on gem-difluoro synthesis. 
 With the optimized condition for dihydrofluorination of an alkyne in hand, we 
investigated the substrate scope of this transformation (Table 8). This reaction worked very 
well for both terminal and internal alkynes. 





The usefulness of our method was further validated by the synthesis of 
fluorocarbocycles via ring-closing metathesis (RCM) reactions (Scheme 7).49 Because 
fluoroalkenes can be prepared efficiently using our new method and alkene groups are well 
tolerated, we can envision a diverse set of fluorocycles made by the combination of alkyne 
mono-hydrofluorination and RCM reactions. 
 
Scheme 7. Synthesis of fluorocarbocycles. 
2.4 Conclusion  
 In conclusion, our new fluorination reagent DMPU-HF not only is easily handled 
but also is an efficient fluorination system for the regioselective mono- and di-
hydrofluorination of alkynes. Further applications of this new fluorination reagent are 
currently being conducted in our laboratory. 
2.5 Experimental section 
General experimental information 
1H and 13C NMR spectra were recorded at 500 and 126 (or 400 and 101) MHz 
respectively, while 19F was recorded at 376 MHz using CDCl3
 
as a solvent. The chemical 
shifts are reported in δ (ppm) values (1H and 13C NMR relative to CHCl3,
 
δ 7.26 ppm for 
1H NMR and δ 77.0 ppm for 13C NMR, multiplicities are indicated by s (singlet), d 
(doublet), t (triplet), q (quartet), p (pentet), h (hextet), m (multiplet) and br (broad). 
Coupling constants, J, are reported in Hertz (Hz). All air and/or moisture sensitive reactions 
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were carried out under argon atmosphere. Solvents (1,2-dichloroethane and 
dichloromethane) were chemically dried using a commercial solvent purification system. 
All other reagents and solvents were employed without further purification. The products 
were purified using a commercial flash chromatography system or a regular glass column. 
TLC was developed on Merck silica gel 60 F254 aluminum sheets.  
Gold pre-catalyst (Au-1) was prepared using our published procedure.68  
Preparation of DMPU-HF complex (HF 65% w/w) 
DMPU (5 g) was added into a long Teflon tube, the Teflon tube was cooled to 0oC, 
and 9.3g of HF gas was condensed into the Teflon tube under stirring. The obtained liquid 
was stored in a 25 mL Teflon vial with a screw cap at room temperature.  
The boiling point of DMPU-HF complex (HF 65% w/w) is around 50-120 oC. The 
boiling point is not well defined (HF evaporates continuously in the range of 50-120 oC). 
 
We also conducted HF loss experiment in open air at 55oC (the reaction temperature 
we used in our synthetic applications). In a well-vented fume hood, 1 gram of DMPU-HF 
complex (HF 65% w/w) was added to 5 mL polypropylene vial, the vial was heated to 55oC 
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in open air (without cap), and we measured the weight of polypropylene vial periodically. 
We calculated the percent of HF left over time (we assumed evaporation of DMPU was 
negligible).  
General procedure for synthesis of fluoroalkene 2-2 
Reactions were performed in 5 mL polypropylene vials with cone-lined caps. GC-MS and 
19F NMR analysis were used to monitor the progress of reactions. 
Using synthesis of 2-2a as an example: 
 
To a solution of 5-phenyl-1-pentyne 2-1a (14.4 mg, 0.10 mmol) in DCE (0.5 mL) in a 
polypropylene vial, imidogold precatalyst Au-1 (2 mol%, 0.01 M stock solution in DCE) 
was added at room temperature. The reaction mixture was stirred for 3 h at 55oC. Upon 
completion, the reaction was quenched with saturated sodium bicarbonate. The mixture 
was extracted with hexane and washed with brine; the organic layer was collected, dried 
over anhydrous MgSO4 and filtered. The solvent was removed under reduced pressure and 
the residue was subjected to flash column chromatography purification (eluent: hexane) to 
give fluoroalkene 2-2a as a colorless oil. 
General procedure for synthesis of gem-difluoromethylene compounds 3 




To a solution of 5-phenyl-1-pentyne (14.4 mg, 0.10 mmol) in DCE (0.5 mL), imidogold 
precatalyst Au-1 (2 mol% from a 0.01 M solution in DCE), KHSO4 (1.5 equiv) were added 
at room temperature. The mixture was stirred for 24 h at 55 oC. Upon completion, the 
reaction was quenched with saturated sodium bicarbonate. The mixture was separated with 
hexane and washed with brine; the organic layer was collected, dried over anhydrous 
MgSO4 and filtered. The solvent was removed under reduced pressure and the residue was 
subjected to flash column chromatography purification (eluent: hexane) to give 3a as a 
colorless oil.  
Spectroscopic data of 2-2 and 2-3 
(4-Fluoropent-4-en-1-yl) benzene (2-2a) 
 
1H NMR (400 MHz, CDCl3) δ 7.27 – 7.18 (m, 5H), 4.52 (dd, J = 17.6, 2.6 Hz, 1H), 4.31 – 
4.12 (m, 1H), 2.66 (t, J = 7.7 Hz, 2H), 2.27 – 2.13 (m, 2H), 1.92 – 1.78 (m, 2H).19F NMR 
(376 MHz, CDCl3) δ -94.91 (ddd, J = 50.0, 33.4, 16.4 Hz, 1H).
13C NMR (101 MHz, 
CDCl3) δ 141.62, 128.41, 128.34, 125.89, 89.80, 89.60, 34.89, 31.56, 31.38, 31.11, 27.60, 
22.63. HRMS (EI+) for C11H13F Cald = 164.1001, found 164.1001.  




19F NMR (CCl4) -93.5 ppm (CFCl3) (m). Its spectroscopic data is consistent with a 
literature report.69 
(3-Fluorobut-3-en-1-yl) benzene (2-2c)  
 
1H NMR (400 MHz, CDCl3): δ = 2.46-2.62 (m, 2H), 2.48-2.92 (m, 2H), 4.45 (dd, 
2JH-F = 
50.0 Hz, J = 2.5 Hz, 1H), 4.61 (dd, 2JH-F = 18.0 Hz, J = 2.5 Hz, 1H), 7.22-7.33 (m, 3H), 
7.47-7.55 ppm (m, 2H); 19F NMR (470 MHz, CDCl3): d = -95.5 ppm (dq, 
3JF-H(olefin)=49.8 
Hz, 3JF-H = 




1H NMR (400 MHz, CDCl3) δ 4.59 (dd, J = 17.2, 3.0 Hz, 1H), 4.31 (dd, J = 49.7, 2.9 Hz, 
1H), 2.48 – 2.28 (m, 4H), 1.87 (m, 2H).19F NMR (376 MHz, CDCl3) δ -97.09 (m, 1F).
13C 
NMR (100 MHz, CDCl3) δ 165.25, 162.69, 118.95, 91.68, 91.48, 30.71, 30.43, 21.83, 
16.16. HRMS (ESI+) Calcd. for C6H9FN 114. 0719, found 114.0720.  




Following general procedure for synthesis of 2 except ratio of phenylacetylene and DMPU-
HF is 2:1. 1H NMR (500 MHz, CDCl3): δ 7.57-7.55 (m, 2H), 7.38-7.37 (m, 3H), 5.04 (dd, 
1H, J = 49.7; 3.4 Hz), 4.85 (dd, 1H, J = 17.7, 3.4 Hz). 19F NMR (282 MHz, CDCl3): δ –
108.47 (dd, 3JHF = 51.9; 18.3 Hz). Its spectroscopic data is consistent with a literature 
report.50a 
1-(1-Fluorovinyl)-4-(trifluoromethyl)benzene (2-2f)  
 
1H NMR (CDCl3, 300 MHz): δ 4.98 (dd, 1 H, J = 17.5, 3.7 Hz), 5.14 (dd, 1H, J = 48.9, 3.7 
Hz, HB), 7.58–7.70 (m, 4H). 
19F NMR (CDCl3, 282 MHz): d 63.42 (s, 3F, CF3), -108.72 
(dd, 1F, J = 50.8, 17.7 Hz, 1-CF). Its spectroscopic data is consistent with a literature 
report.70 
1-(1-Fluorovinyl)-4-methoxybenzene (2-2g)  
 
Following general procedure for synthesis of 2 except ratio of phenylacetylene and DMPU-
HF is 2:1. 1H NMR (CDCl3, 400 MHz) δ 7.50 (d, J = 8.8 Hz, 2 H), 6.90 (d, J = 8.7 Hz, 2 
H), 4.89 (dd, J = 3.4, 50.2 Hz, 1 H), 4.74 (dd, J = 3.4, 18.1 Hz, 1 H), 3.84 (s, 3 H) ppm. 19F 
NMR (CDCl3, 376 MHz) δ –107.2 (dd, 
3JF–H = 18.1, 50.0 Hz, 1F). Its spectroscopic data 





1H NMR (400 MHz, CDCl3) δ 7.89 – 7.80 (m, 2H), 7.72 (dt, J = 4.5, 3.6 Hz, 2H), 4.52 (dd, 
J = 17.5, 2.2 Hz, 1H),4.28 (dd, J = 50.2, 2.1 Hz, 1H), 3.73 (t, J = 7.1 Hz, 2H), 2.25 (dt, J = 
15.3, 7.6 Hz, 2H), 1.99 – 1.83 (m, 2H).19F NMR (376 MHz, CDCl3) δ -95.15 (m, 1F).
13C 
NMR (101 MHz,CDCl3) δ 168.31, 166.63, 164.08, 133.96, 132.02, 123.23, 90.28, 90.08, 
77.32,77.00, 76.68, 37.16, 29.45, 29.17, 25.04. HRMS (CI+) calcd. for C13H13FNO2 234. 
0930, found 234. 0930. 
(Z)-Ethyl 3-fluoro-3-phenylacrylate (2-2i)  
  
1H NMR (400 MHz, CDCl3), δ 7.62 (d, J = 7.6 Hz, 2H), 7.38-7.47 (m, 3H), 5.88 (d, J = 
33.4 Hz, 1H), 4.23 (q, J = 7.2 Hz, 2H), 1.30 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ 166.1 (d, J = 275.9 Hz), 163.90 (d, J = 2.3 Hz), 125.5 (d, J = 8.0 Hz), 97.1 (d, J 
= 6.8 Hz), 60.3, 14.1. 19F NMR (376 MHz, CDCl3) δ -96.16 (d, J = 33 Hz, 1F). Its 
spectroscopic data is consistent with a literature report.72 




1H NMR (CDCl3, 400 MHz) δ 7.67–7.69 (m, 4 H), 7.37–7.46 (m, 5 H), 7.27–7.31 (m, 1 
H), 6.34 (d, J = 39.5 Hz, 1 H) ppm. 19F NMR (CDCl3, 376 MHz) δ –114.2 (d, 
3JF–H = 39.9 
Hz). Its spectroscopic data is consistent with a literature report.73 
(Z)-5-Fluorodec-5-ene (2-2k)  
 
1H NMR (400 MHz, CDCl3) δ = 4.46 (dt, J = 38.4, 7.2 Hz, 1H), 2.14 (dt, J = 17.2, 7.2 Hz, 
2H), 2.08-2.03 (m, 2 H), 1.51-1.43 (m, 2H), 1.39-1.28 (m, 6H),0.95-0.88 (m, 6H); 19F NMR 
(376 MHz, CDCl3) δ–110.7 (dt, J = 38.4, 16.9 Hz). Its spectroscopic data is consistent with 
a literature report.74 
Dimethyl 2-(2-fluoroallyl)malonate (2-2l) 
 
1H NMR (700 MHz, CDCl3) δ 4.59 (dd, J = 17.0, 2.6 Hz, 1H), 4.33 (dd, J = 49.4, 2.8 Hz, 
1H), 3.73 (s, 3H), 3.65 (s, 3H), 2.81 (dd, J = 17.0, 7.6 Hz, 2H).19F NMR (470 MHz, CDCl3) 
δ -97.34 (m, 1F).13C NMR (176 MHz, CDCl3) δ 168.58, 166.89, 92.34, 92.23, 52.78, 52.53, 
48.80, 41.10, 31.47, 31.31. EI-HR MS (ESI +) Calcd for C8H11FO4 = 190.0641, found: 
190.0639. 




1H NMR (500 MHz, CDCl3): δ 5.67 (dd, 1H, J = 43.5; 3.4 Hz), 5.31 (dd, 1H, J = 13.2; 3.4 
Hz), 4.30 (q, 2H, J = 7.2 Hz), 1.34 (t, 3H, J = 7.1 Hz). 19F NMR (282 MHz, CDCl3): δ –
117.72 (d, 3JHF = 42.7 Hz). Its spectroscopic data is consistent with a literature report.
75 
Pure 2m was not isolated due to its volatility. 
(4, 4-Difluoropentyl)benzene (2-3a) 
 
19F NMR (376 MHz, CDCl3) δ -90.529 (m, 1F). HRMS (EI +) calcd. for C11H14F2 
184.1064; found 184.1064. Note: The product 2-3a is very volatile and usually cyclizes on 
silica gel chromatography to an unidentifiable product, so analytically pure 2-3a couldn’t 
be obtained. 
(1,1-Difluoroethyl)benzene (2-3b)  
 
19F NMR (376 MHz, CDCl3) δ -87.16 (q, J =18.6 Hz). Its spectroscopic data is consistent 
with a literature report.76 
1-(1,1-Difluoroethyl)-4-methoxybenzene (2-3c) 
 
19F NMR (376 MHz, CDCl3) δ -86.4 (q, J =18.6 Hz). Its spectroscopic data is consistent 





19F NMR (376 MHz, CDCl3) δ -86.08 (q, J = 19.0 Hz, 2F), -113.17 (m, 1F). Its 
spectroscopic data is consistent with a literature report.78 
2-(4,4-Difluoropentyl)isoindoline-1,3-dione (2-3e)  
 
1H NMR (400 MHz, CDCl3) δ 7.88-7.83 (m, 2H), 7.76-7.70 (m, 2H), 3.74 (t, J = 6.6 Hz, 
2H), 1.93-1.87 (m, 4H), 1.59 (t, JHF = 18.4 Hz, 3H).
 19F NMR (282 MHz, CDCl3) δ -91.4 
(m). Its spectroscopic data is consistent with a literature report.79 
(1,1-difluoroethane-1,2-diyl)dibenzene (2-3f) 
  
1H NMR δ: 3.46 (t, 2H, J = 15.8 Hz), 7.13-7.16 (m, 2H), 7.28-7.30 (m, 3H), 7.37-7.42 (m, 








3 PREPARATION OF FLUORINATED 
TETRAHYDROPYRANS AND PIPERIDINES USING A NEW 
NUCLEOPHILIC FLUORINATION REAGENT–DMPU-HF 
3.1 Background 
The Prins cyclisation reaction is a reaction leading to a tetrahydropyran from a 
homoallylic alcohol and an aldehyde in the presence of a Lewis or Brønsted acid and a 
nucleophile. Common nucleophiles used for this reaction are bromide,81 chloride,82 
iodide,81a acetate81b, 83_ENREF_92 and tosylate.83a 
 
Scheme 8: General case for the Prins reaction. 
Though Ballard reported the first synthesis of pyran via the Prins cyclization 
reaction84 the Prins reaction was first reported by Kriewitz in 1899, described as the 
condensation of an olefin and an aldehyde to give rise to unsaturated alcohols.85 However, 
it was not until 1919 that a comprehensive study was carried out by H. J. Prins.86 He 
performed reactions with styrene, α-pinene and camphene with formaldehyde using water 
or glacial acetic acid as solvent. From his study (Scheme 9), it was reported that with water 
as solvent, unsaturated alcohols or 1,3-butanediols were obtained while with glacial acetic 
acid, esters from acetic acid were usually obtained. Today these types of reaction that 
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involve the condensation of an olefin with an aldehyde in the presence of an acid is often 
called the Prins reaction. 
 
Scheme 9. Example of the condensation reaction carried out by H.J Prins in 1919. 
The tetrahydropyran motif is quite common in many natural products and this has 
led to the development of a vast array of synthetic methodologies to access the tetrahydro 
pyran rings effectively.  
3.2 Fluoro-Prins cyclization reaction  
Investigation of the literature reveals very few examples of the Prins fluorinaton 
reaction. Reported cases of 4-fluorotetrahydropyran synthesis appeared as an unexpected 
by-product of the Prins cyclization reaction. This observation was first made by 
Rychnovsky81b, 87 et al. in 1996 when BF3.OEt2 was used as Lewis acid to promote oxygen 
substitution at the 4-position of the tetrahydropyran moiety Scheme 10. 
 
Scheme 10. Prins cyclizattion leading to the fluorinated pyran. 
They, however, observed an accidental deviation from their synthetic target with 
the substitution of the fluorine atom instead. Ever since, few other cases of the fluoro-Prins 
reaction have been reported.88  
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3.3 Fluoro-Prins reaction with DMPU-HF 
As earlier stated, the Prins reaction81a, 89 of a homoallylic alcohol and an aldehyde 
in the presence of an acid is a well-established synthetic methodology for the preparation 
of tetrahydropyrans.86, 90 However, there are only few reports on the Prins reaction for the 
synthesis of fluorinated tetrahydropyrans.88a, 88c, 91 Most of the reported syntheses of 
fluorinated tetrahydropyrans utilize a strong Lewis acid, BF3∙OEt2, as the fluorine source. 
Hence, they suffer from low yields and especially low diastereoselectivity88c. Fuchigami 
and coworkers reported the synthesis of 4-fluoro-tetrahydropyrans with HF salts in liquid 
form, but a large excess of HF was needed (HF as solvent).88a Because the Prins reaction 
requires an acidic medium, the more acidic HF/DMPU system should improve the 
efficiency of Prins cyclization. Since DMPU-HF reagent is more acidic than Olah’s reagent 
(pyridine∙9HF) or triethylamine HF (Et3N∙3HF). We propose that its use could be 
advantageous in fluorination reactions that require a highly acidic medium.  
 We began our study on the fluoro-Prins reaction by first reacting the homoallylic 
alcohol 3-1 and benzaldehyde 3-2a in the presence of DMPU-HF in different solvents. We 
were pleased to find that the reaction of homoallylic alcohol 3-1 and benzaldehyde 3-2a in 
the presence of DMPU-HF produced the expected 4-fluorotetrahydropyran 3-3a (Table 9). 
Reactions in a number of nonpolar solvents (hexane, toluene, and DCM) provided high 
efficiency and excellent diastereoselectivity (Table 9, entries 1-3). A lower concentration 
of HF in the reaction medium (34% HF/DMPU wt/wt, DMPU:HF = 1: 3.3) slowed down 
the reaction, but the diastereoselectivity was maintained (Table 9, entry 4). A complete 
replacement of solvent by DMPU resulted in a much slower conversion and eroded the 
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diastereomeric ratio (Table 9, entry 5). Reactions were completely shut down in Lewis 
basic solvents, including THF and DMF (Table 8, entry 6, 7).  
Table 9. Optimization of the fluoro-Prins reaction. 
 
Entry Solvent time / h conversion 
/ % 
cis/transb 
1 Hexane 3 100 17:1 
2 Toluene 3 100 17:1 
3 DCM 3 96 17:1 
4c DCM 9 90 17:1 
5 DMPU 3 42 10:1 
6 THF 9 0 - 
7 DMF 9 0 - 
a)1 (0.2 mmol), 2 (0.2 mmol), DMPU-HF (2.1 mmol of HF) and solvent (0.5 mL) was mixed in a 
polyethylene vial, then stirred for 3-9 h at rt; b) determined by 19F NMR. c34 % DMPU-HF. 
We also compared the reactivity and selectivity of Olah’s reagent and HF/DMPU 
in the Prins reaction of 2-naphthaldehyde (Scheme 11). The more acidic DMPU-HF 
reagent enabled a faster conversion and much better diastereoselectivity than Olah’s 
reagent. The origin of this diastereoselectivity is still not clear to us, however, we think that 
the steric imposition from the structure of DMPU may be playing an important role in 




Scheme 11. Reactivity and selectivity of Olah’s reagent and DMPU-HF on fluoro-Prins 
reaction. 
To explore the general applicability of our methodology, several aldehydes were 
subjected to our optimized reaction conditions (Table 10). Aromatic and aliphatic 
aldehydes gave the corresponding fluorinated tetrahydropyrans in good yields and good 
diastereoselectivity. A more electron-rich aldehyde, such as 4-hydroxy-3,5-
dimethoxybenzaldehyde, did not react under these conditions. The same phenomenon was 
also observed in the BF3∙OEt2-mediated Prins cyclization
88c (Table 10, entry 10).   
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Table 10. Scope of the fluoro-Prins reaction. 
 
Entry R 3 yield (%) cis-3/trans-3b 
1 C6H5- 3-3a 75 17:1 
2 2-naphtyl 3-3b 74 > 20:1 
3 4-Cl-C6H4- 3-3c 87 > 20:1 
4 4-Br-C6H4- 3-3d 91 > 20:1 
5 4-NO2-C6H4- 3-3e 81 > 20:1 
6 4-CF3-C6H4- 3-3f 92 > 20:1 
7 4-i-Pr-C6H4- 3-3g 78 > 20:1 
8 4-Me-C6H4- 3-3h 72 > 20:1 
9 2-NO2-C6H4- 3-3i 76 > 20:1 
10 4-OH-3,5-
dimethoxy-C6H2 
3-3j No rxn - 
11 6-Br-2-OH-3-
MeO-C6H2 
3-3k 56 > 20:1 
12 cyclohexyl- 3-3l 88 20:1 
a)1 (0.2 mmol), 2 0.2 mmol, DMPU-HF (2.1 mmol HF) in DCM 0.5 mL was mixed in a plastic vial, and 
was stirred for 3 h at rt. b) determined by 19F NMR. 
3.4 Aza-Prins fluorination reaction 
In the case of the aza-Prins reaction, the alcohol is replaced by an amine and this 
type of reaction has been widely explored. Weinreb92 in 1988 reported the intramolecular 
aza-Prins cyclization where an aldehyde was converted to the tosyl iminium intermediate 




Scheme 12. Weinreb’s example of aza-Prins cyclization reaction. 
Several natural products like (+)-cortisatin A (an anti-angiogenic steroidal alkaloid) 
have been synthesized via this methodology.93 More recently, the aza Prins cyclization 
reaction has gained increased interest and there have been several report to the formation 
of piperidines from the homoallylic amines and aldehydes in the presence of a variety of 






 which has led 
to the incorporation of various nucleophiles such as Cl-, Br-, I- and more recently F- where 
BF3.OEt2
88c and Et4NF/5HF
88a were the acids used. 
We investigated the aza-Prins cyclization of aldehyde and N-tosyl homoallyl amine 
in the presence of our DMPU-HF reagent. As shown in Table 11, the reaction of N-tosyl 
homoallyl amine 3-11 with aliphatic aldehydes furnished the corresponding 
fluoropiperidines 3-12 in excellent yields and good diastereoselectivity after a few hours. 
Similar to previous literature reports,99 this reaction did not proceed well with aryl 
aldehydes (Table 11, entries 3-5), and longer reaction times were needed in order to achieve 
a full conversion. The reaction became very sluggish with an electron rich aromatic 
aldehyde (e.g. anisaldehyde) and only trace amount of product was obtained even after an 
extended reaction time (Table 11, entry 6).  
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Table 11. Scope of the aza-Prins fluorocyclization. 
 
Entry R time (h) 3-11 yield (%) cis-5/trans-3-12b 
1 Cyclohexyl- 4 3-11a 100 10:1 
2 n-C5H11- 4 3-11b 100 8.5:1 
3 Ph 24 3-11c 96 2:1 
4 4-Br-C6H4- 24 3-11d 90 2.5:1 
5 4-NO2-C6H4- 24 3-11e 42 2:1 
6 4-MeO-C6H4- 48 3-11f 0 - 
a)4 (0.2 mmol), 2 (0.2 mmol), DMPU-HF (2.1 mmol of HF) in DCE 0.5 mL was mixed in a polyethylene 
vial, then stirred at 55 ◦C; b) determined by 19F NMR. c) room temperature; d) determined by 19F NMR 
using PhCF3 as internal standard. 
3.5 Mechanism and stereochemistry of fluoro-Prins cyclization 
reaction 
The mechanism of the Prins cyclization reaction has been investigated by several 
research groups.83a, 100 and our proposed mechanism for this project with DMPU-HF 




Scheme 13. Proposed mechanism for the fluoro-Prins cyclization. 
The proposed mechanism of the fluoro-Prins cyclization reaction is shown in 
Scheme 13. First, DMPU-HF activates the aldehyde 3-2, which then reacts with the 
homoallylic alcohol. Subsequent elimination of water results in the formation of the 
intermediate oxonium ion C that then cyclizes into carbocation D. The nucleophilic 
fluorine in DMPU-HF quenches intermediate D to give the fluorinated product 3-3.81b, 82, 
101  
Theoretical calculations by Alder and co-workers showed syn-diastereoselective 
preference for the Prins cyclization reaction.90 Going by the general mechanism of the Prins 
reaction, Alder et al observed that the oxonium ion C forms the more favorable chair-like 




Scheme 14. Plausible stereochemical outcome for the Prins cyclization 
 
Using the B3LYP/6-31G computer model, Alder reported further that the C+-H 
bond of D was semiaxial in the chair 4-tetrahydropyranyl cation and it is the most stable 
conformation. Hence, the nucleophilic attack occurred from the equatorial position given 
rise to the syn products.  The work of David O’Hagan et al88c on the synthesis of 4-fluoro 
substituted tetrahydropyrans via the Prins reaction lend support to the syn 
diasteroselectivity observed in the products. They obtained 3-3e from the reaction of the 
corresponding homoallylic alcohol and 4-nitrobenzaldehyde in the presence BF3.OEt2 in a 
10:1 diastereomeric ratio and unambiguously confirmed its syn stereochemical outcome 
via X-ray crystallography. Using the spectroscopic data (1H, 19F, and 13C) of 3-3e, they 
were able to characterize the syn products of other substrates.  
We were able to determine the diastereoselectivity of our products by comparing the 
spectroscopic data of our results with the data given by Fuchigami and David O’Hagan.88a, 
88c Most of the substrates we experimented in this reaction were similar to the substrates 





In summary, DMPU-HF is a suitable nucleophilic fluorination reagent for the 
diastereoselective synthesis of substituted 4-fluorotetrahydropyrans and 4-
fluoropiperidines via the Prins reaction. When compared to other commonly used 
nucleophilic fluorination reagents like pyridine/HF, DMPU-HF gives both higher yields 
and better cis/trans selectivity. Aside the fact that DMPU-HF is more acidic than the 
common HF-based reagents like Et3N.3HF and Py/HF, which we believe is important in 
facilitating the success of the fluoro-Prins cyclization reaction, we are yet to be sure of its 
role in enhancing better cis/trans selectivity when compared with these other reagents. We 
hope that the on-going computational analysis will help us understand the role of DMPU-




3.7 Experimental section 
1. General Information 
NMR spectra were recorded on a 400 MHz or a 500 MHz spectrometer. Chemical 
shifts are given in ppm. The spectra are calibrated to the residual 1H and 13C and 19F signals 
of the solvents. Multiplicities are abbreviated as follows: singlet (s), doublet (d), triplet (t), 
quartet (q), doublet-doublet (dd), quintet (quint), septet (sept), multiplet (m), and broad 
(br).  
Unless otherwise stated, starting materials were purchased from Aldrich and/or 
Fluka. Solvents were used as purchased. Conversion was monitored by thin layer 
chromatography (TLC) using Merck TLC silica gel 60 F254. Compounds were visualized 
by UV-light at 254 nm and by dipping the plates in an polymoybdenic acid (PMA), p-
anisaldehyde, solutions or an aqueous potassium permanganate solution followed by 
heating, depending on the compounds formed.  
2. General method for the oxa-Prins fluorocyclization reaction 
 
In a polyethylene vial charged with a magnetic stirring bar, homoallylic alcohol 3-
1 (0.2 mmol) and aldehyde 3-2 (0.2 mmol) were dissolved in 0.5 mL dichloromethane, 
then DMPU-HF (HF content 65 % wt/wt, 58 µL, 2.1 mmol) was added to the mixture and 
was stirred for 3 h at room temperature. The progress of reaction can be monitored by TLC 
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(green or dark brown dots on anisaldehyde stain). After completion of the reaction the 
mixture was quenched with cold water, and the organic phase was extracted with 
chloroform (5 mL). The organic phase was washed with aqueous sodium bicarbonate, a 2 
M solution of sodium bisulfite and brine. Finally the organic phase was dried over sodium 
sulfate and was concentrated to dryness in vacuum. The crude product was 
chromatographed with a 10:1 mixture of hexanes and EtOAc to afford the corresponding 
fluoro-tetrahydropyrans 3-3. 
3. General method for the aza-Prins fluorocyclization reaction 
 
In a polyethylene vial charged with a magnetic stirrer, homoallylic tosylamine (0.2 
mmol) and aldehyde 3-2 (0.2 mmol) were dissolved in 0.5 mL dichloroethane, then 
DMPU-HF (HF content 65 % wt/wt, 58 µL, 2.1 mmol) was added to the mixture and was 
stirred for 3 h at 55 oC. The progress of reaction can be monitored by TLC (green or dark 
brown dots on anisaldehyde stain). After completion of the reaction, the mixture was 
quenched with cold water, and the organic phase was extracted with chloroform (2 mL). 
The organic phase was washed with aqueous sodium bicarbonate, a 2M solution of sodium 
bisulfite and brine. Finally the organic phase was dried over sodium sulfate and was 
concentrated to dryness in vacuum. The crude product was chromatographed with a 10:1 
mixture of hexanes and EtOAc to afford the corresponding fluoro-piperidine 3-12. 





Colorless oil, (24.7 mg)1H NMR (400 MHz, CDCl3): δ 7.35–7.22 (m, 5 H), 4.95–4.65 (m, 
JH,F = 49.1 Hz, 1 H), 4.33–4.27 (m, 1 H), 4.24–4.15 (m, 1 H), 3.60–3.49 (m, 1 H), 2.38–
2.28 (m, 1 H), 2.15–2.06 (m, 1 H), 1.94–1.68 (m, 2H). Its spectroscopic data is consistent 
with a literature report.88a, 91a 
4-Fluoro-2-(naphthalen-1-yl)tetrahydro-2H-pyran(3-3b) 
 
Brown solid, (34 mg). 1H NMR (400 MHz, CDCl3) δ 8.01 – 7.73 (m, 4H), 7.59 – 7.34 (m, 
3H), 5.01 – 4.72 (dtt, J= 49.0 Hz, 10.7 Hz, 5.1 Hz. 1H), 4.50 (d, J = 11.3 Hz, 1H), 4.27 (dd, 
J = 11.6, 5.6 Hz, 1H), 3.63 (t, J = 12.3 Hz, 1H), 2.62 – 2.34 (m, 1H), 2.25 – 2.06 (m, 1H), 
2.01 – 1.72 (m, 2H).13C NMR (100 MHz, CDCl3) δ 138.67, 133.26, 133.01, 128.26, 
128.00, 127.65, 126.17, 125.94, 124.57, 123.95, 109.99, 89.39 (d, J = 177.2 Hz), 77.88 (d, 
J = 11.4 Hz), 65.54 (d, J = 11.9 Hz), 40.57 (d, J = 17.1 Hz), 33.01 (d, J = 17.7 Hz). 19F 
NMR (376 MHz, CDCl3) δ -169.74 (d, J = 49.0 Hz, 1F). MS: m/z= 230.11 ([M]
 +). ESI 
HRMS: calcd. for C15H15FONa
+ ([M+Na]+) 253.0999; found 253.0999. 




Semisolid, (36.4 mg). 1H NMR (CDCl3, 400 MHz): δ 7.27–7.35 (4 H, m) 4.72–4.92 (1 H, 
m), 4.30 (1 H, dd, J = 11.6, 2.0 Hz), 4.18–4.24 (1 H, m), 3.56 (1 H, tt, J = 12.4, 1.6 Hz), 
2.28–2.37 (1 H, m), 2.10–2.17 (1 H, m), 1.85 (1 H, dp, J = 11.2, 4.8 Hz), 1.71 (1 H, p, J = 
10.0 Hz). Its spectroscopic data is consistent with a literature report.91a 
2-(4-Bromophenyl)-4-fluorotetrahydro-2H-pyran (3-3d) 
 
Brown solid, (46.4 mg) Cis isomer: 19F NMR (CDCl3, 376 MHz): δ - 171.1 (m); trans 
isomer: 19F NMR (CDCl3, 376 MHz) δ -186.3 (m). Its spectroscopic data is consistent with 
a literature report.88c 
4-Fluoro-2-(4-nitrophenyl)tetrahydro-2H-pyran (3-3e)  
 
Yellow solid (36.1mg) Cis isomer: 19F NMR (CDCl3, 376 MHz): δ - 170.5 (m); trans 
isomer 19F NMR (CDCl3, 376 MHz) δ -185.3 (m). Its spectroscopic data is consistent with 




4-Fluoro-2-(4-(trifluoromethyl)phenyl)tetrahydro-2H-pyran (3-3f)  
 
Yellow solid, (45.3 mg). This compound is known:1H NMR (CDCl3, 400 MHz): δ 7.61 (2 
H, d, J = 8.0 Hz), 7.46 (2 H, d, J = 8.0 Hz), 7.46 (2 H, d, J = 8.0 Hz), 4.73–4.93 (1 H, m), 
4.37 (1 H, dd, J = 11.2, 2.0 Hz), 4.20–4.26 (1 H, m), 3.57 (1 H, tt, J = 14.0, 2.0 Hz), 2.32–
2.39 (1 H, m), 2.10–2.20 (1 H, m), 1.80–1.92 (1 H, m), d 1.63–1.75 (m, 1 H). Its 
spectroscopic data is consistent with a literature report.91a  
4-Fluoro-2-(4-isopropylphenyl)tetrahydro-2H-pyran (3-3g) 
 
Yellow solid, (33.9 mg): 1H NMR (400 MHz, CDCl3) δ 7.67 – 6.84 (m, 5H), 5.04 – 4.56 
(m, 1H), 4.37 – 4.26 (m, 1H), 4.20 (dt, J = 11.6, 5.7 Hz, 1H), 3.56 (td, J = 12.4, 1.5 Hz, 
1H), 2.97 – 2.81 (m, 1H), 2.45 – 2.28 (m, 1H), 2.18 – 2.06 (m, 1H), 1.93 – 1.72 (m, 2H), 
1.25 (dd, J = 6.9, 1.5 Hz, 6H).13C NMR (100 MHz, CDCl3) δ 148.61, 138.51, 130.37, 
126.60, 126.53, 125.97, 89.47 (d, J = 176.8 Hz), 77.76 (d, J = 11.4 Hz), 65.44 (d, J = 11.9 
Hz), 40.27 (d, J = 16.9 Hz), 34.34 (s, 4H), 33.84 (s, 13 H), 33.00 (d, J = 17.5 Hz), 
23.9823.67. 19F NMR (376 MHz, CDCl3) δ -169.65 (dd, J = 49.2, 4.5 Hz, 1F). MS: m/z 
222.1 [M] +. ESI HRMS: calcd. for C14H20FO




4-Fluoro-2-(p-tolyl)tetrahydro-2H-pyran (3-3h)  
 
Colorless oil, (28 mg). 1H NMR (400 MHz, CDCl3): δ = 7.22 (d, J = 8.1 Hz, 2 H), 7.14 (d, 
J = 8.1 Hz, 2 H), 4.92–4.62 (m, JH,F = 49.1 Hz, 1 H), 4.28–4.12 (m, 2H), 3.57–3.47 (m, 1 
H), 2.32 (s, 3 H), 2.30–2.24 (m, 1 H), 2.12–2.04 (m, 1 H), 1.92–1.66 (m, 2 H). Its 
spectroscopic data is consistent with a literature report.88a 
4-Fluoro-2-(2-nitrophenyl)tetrahydro-2H-pyran (3-3i)  
 
Yellow oil, (33.6 mg). 1H NMR (CDCl3, 400 MHz): d 1.57–1.67 (1 H, m), 1.81–1.93 (1 
H, m), 2.12–2.18 (1 H, m), 2.58–2.65 (1 H, m), 3.58 (1 H, tt, J = 12.4, 1.6 Hz), 4.17–4.24 
(1 H, m), 4.70 (1 H, dd, J = 11.2, 2.0 Hz), 4.78–4.98 (1 H, m), 4.90 (1 H, dd, J = 12.8, 1.6 
Hz), 7.42–7.47 (1 H, m), 7.64–7.68 (1 H, m), 7.81 (1 H, d, J = 8.0 Hz), 7.94 (1 H, d, J = 
8.0 Hz). Its spectroscopic data is consistent with a literature report.91a 
3-Bromo-2-(4-fluorotetrahydro-2H-pyran-2-yl)-6-methoxyphenol (3-3k) 
 
Dark brown solid (33.7 mg):1H NMR (400 MHz, CDCl3) δ 7.01 (d, J = 8.7 Hz, 1H), 6.68 
(d, J = 8.7 Hz, 1H), 4.94 (d, J = 11.8 Hz, 1H), 4.91 – 4.70 (m, 1H), 4.37 – 4.25 (m, 1H), 
3.85 (s, 3H), 3.62 (t, J = 12.5 Hz, 1H), 2.48 – 2.36 (m, 1H), 2.22 – 2.10 (m, 1H), 1.99 – 
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1.82 (m, 2H).13C NMR (100 MHz, CDCl3) δ 148.35, 146.36, 123.48, 112.37, 111.69, 87.84 
(d, J = 178.8 Hz), 79.71 (d, J = 12.4 Hz), 66.11 (d, J = 12.1 Hz), 56.16, 36.72 (d, J = 18.1 
Hz), 32.78 (d, J = 18.6 Hz). 19F NMR (376 MHz, CDCl3) δ -171.10 (d, J = 46.8 Hz, 1F). 
MS: m/z = 304.01 [M] +. ESI HRMS: calcd. for C12H15FO3Na
+ 327.0003; found 327.0003, 
cald. For C12H16FO3
+ ([M+H]+) 305.0183; found 305.0183. 
2-Cyclohexyl-4-fluorotetrahydro-2H-pyran (3-3l)  
 
Light yellow Oil, (33 mg).Cis isomer: 19F (CDCl3, 376 MHz): δ - 168.8 (m); trans isomer: 




Colorless oil, (63.4 mg). Cis isomer: 19F NMR (CDCl3, 376 MHz): δ - 175.2 (m); trans 
isomer: 19F NMR (CDCl3, 376 MHz) δ -178.9(m). Its spectroscopic data is consistent with 




4-Fluoro-2-pentyl-1-tosylpiperidine (3-12b)  
 
Colorless oil, (60.2 mg) Cis isomer: 19F NMR (CDCl3, 376 MHz): δ - 176.1 (m); trans 
isomer: 19F NMR (CDCl3, 376 MHz) δ -179 (m). Its spectroscopic data is consistent with 
a literature report.88c 
4-Fluoro-2-phenyl-1-tosylpiperidine (3-12c)  
 
Colorless oil, (27 mg). Cis isomer: 19F NMR (CDCl3, 376 MHz): δ - 177.2 (m); trans 
isomer: 19F NMR (CDCl3, 376 MHz) δ -179.8 (m). Its spectroscopic data is consistent with 
a literature report.88a 
2-(4-Bromophenyl)-4-fluoro-1-tosylpiperidine (3-12d) 
 
Brown solid, (40 mg) Cis isomer: 19F NMR (CDCl3, 376 MHz): δ - 175.6 (m); trans isomer: 





4-Fluoro-2-(4-nitrophenyl)-1-tosylpiperidine (3-12e)  
 
Light yellow solid, (23.1 mg). Cis isomer: 19F NMR (CDCl3, 376 MHz): δ - 176 (m); trans 
isomer: 19F NMR (CDCl3, 376 MHz) δ -180.1 (m). Its spectroscopic data is consistent with 





4 REGIOSELECTIVE RING OPENING OF AZIRIDINES BY 
DMPU-HF 
4.1 Background 
Among fluorinated compounds, β-fluoroamines are important building blocks and motifs 
in medicinal chemistry (Figure 8),102 thus, efficient synthetic approaches toward β-
fluoroamine motif are in high demand.  
 
Figure 8. β-Fluoroamines in medicinal chemistry. 
In addition to the improved metabolic stability as well as the binding affinity 
offered by drugs containing C-F bonds, β-fluoro substitution lowers the pKa of amines 
(Table 2), which in turn improves bioavailability and increases the blood-brain barrier 
penetration. The past decade has witnessed the development of new and improved methods 




Scheme 15. Synthetic routes toward β-fluoroamines. 
Reported synthetic routes toward β-fluoroamines could be categorized into several 
classes (Scheme 15a): (a) hydrofluorination of N-allylic amines by fluoroantimonic acid,103 
(b) deoxyfluorination of β-aminoalcohols and their derivatives,104 (c) nucleophilic ring 
opening of aziridines by metal fluorides or hydrogen fluoride,105 and (d) electrophilic 
fluorination of imines or other synthetic equivalents and subsequent reduction.106 Among 
these methods, the nucleophilic ring opening of aziridines (Scheme 15a, route c) is ideal 
because of the low cost of reagents, mild reaction conditions, and general accessibility of 
substrates,107 while the production of regioisomers and stereoisomers makes it problematic 
(Scheme 15b).108 Hydrogen fluoride (HF) is one of the most straightforward, and economic 
reagents for this type of transformation. The pioneering work of Wade109 and Laurent110 
demonstrated the use of anhydrous hydrogen fluoride as well as HF-amine reagents34-35, 44, 
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111 to open aziridines (Scheme 15b). However, besides the inconvenient operation of 
anhydrous hydrogen fluoride, these reaction conditions suffer from moderate to low yields, 
production of isomeric mixtures, and side products. In addition, bicyclic aziridines usually 
gave rise to the formation of a mixture of diastereomers. Coutts and co-workers also 
reported the ring-opening of N-tosylaziridines employing pyridine-HF-KF system.112 
However, the yield was not significantly improved under these conditions, and the scope 
of reactive substrates was limited. Recently, Doyle and co-workers reported opening 
aziridines with hydrogen fluoride generated from acyl fluoride, but this method only 
worked well with symmetrical cis-2,3-disubsituted aziridines, also required expensive 
hexafluoroisopropanol as reaction medium.41-42 Considering all these limitations, there is 
a keen need of developing a regioselective and stereospecific method to convert aziridines 
into β-fluoroamines.  
 Our previous work with DMPU-HF113 demonstrated to be an efficient nucleophilic 
fluorination reagent in gold-catalyzed hydrofluorination of alkynes114 and fluoro-Prins 
cyclization reactions.115 DMPU-HF exhibited high reactivity and less interference to metal 
catalyst compared to Olah’s reagent (pyridine-HF) and triethylamine-HF. The improved 
reactivity of DMPU-HF drove us to see if it could solve the long-term existing selectivity 
and efficiency problems in the hydrofluorination of aziridines. 
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4.2 Results and discussions 
Reaction design and optimization 
 We chose the hydrofluorination of 2-methyl N-tosylaziridine 4-1a as model 
reaction (Table 12). We found that by treating 4-1a with 65% DMPU-HF in DCE under 
room temperature, 4-1a was regioselectively converted into the desired 2-fluoropropyl-N-
tosylamine 4-2a with high yield and conservation of tosyl protective group116 (Table 11, 
entry 1). The reaction did not take place in tetrahydrofuran (entry 2), and the addition of 
scandium triflate significantly reduced the yield (entry 3). No substantial effect was 
observed when the amount of DMPU-HF was doubled (Table 11, entry 4). Shorter reaction 
time caused an incomplete conversion, but the material balance remained good (Table 1, 
entry 5). Elevating the reaction temperature did not reduce yield (Table 11, entry 6). On 
the other hand, Olah’s reagent (65% HF in pyridine) provided an incomplete conversion 
within the same time frame, and the material balance and regioselectivity were deteriorated 
(Table 11, entry 7). Another common HF-based reagent, triethylamine trihydrofluoride, 
gave no reaction at all (Table 11, entry 8). The regioselectivity of aziridine ring opening 
by DMPU-HF indicated that this process favored an SN1-like pathway, in which the 
positive charge was developed on a more substituted carbon. On the contrary, reaction 
drifted toward an SN2-like pathway when the less acidic Olah’s reagent was used.  
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Table 12. Development of reaction conditions. 
 
Entry 








1 None > 99 93 (87[d]) >30:1 
2 THF as solvent 0 N/A N/A 
3 
Add 10 mol% of 
Sc(OTf)3 
97 69 >30:1 
4 15 equiv of HF 99 86 >30:1 
5 9 h 54 43 >30:1 
6 55 ℃ > 99[e] 88 >30:1 
7 65% HF-Pyridine 85 78 7:1 
8 3HF·NEt3 0 N/A N/A 
a) Standard reaction conditions: 1 (0.2 mmol), HF 7.5 equiv (65% in DMPU) (1.5 mmol HF) in 0.5 mL of 
dichloroethane (DCE) at room temperature in a sealed polypropylene vial over for 18 h. b) Determined by 
19F NMR using benzotrifluoride as an internal standard. c) Determined by 19F NMR. d) Isolated yield. e) 
Reaction time was shorten to12 h. 
 
The effectiveness of this method was confirmed by ring opening of various N-tosyl 
aziridines (Scheme 16). Hydrofluorination of the mono alkyl-, aryl-, and benzyl-substituted 
N-tosylaziridines 4-4a-4g occurred at the most substituted carbon, providing primary alkyl 
amines 4-5a-5g in good yields (Scheme 16). 2-Ethyl-3-methyl-1-tosylaziridine 1h yielded 
an inseparable mixture of regioisomers and diastereomers under these conditions (Scheme 
16, 4-5h). Gem-disubstituted aziridine 4-4i decomposed significantly under these 
conditions, without yielding isolable amounts of product 4-5i. Cyclic aiziridines 4-4j and 
4-4k were converted into trans-β-fluoroamines 4-5j and 4-5k in good yields and 
diastereoselectivity. Reaction of β-hydroxyl cyclic aziridine 4-4l took place at less hindered 
side with the retention of hydroxyl group, and X-ray crystallography confirmed the 
62 
 
configuration of 4-5l. Trisubstituted aziridines 4-4m and 4-4n were fluorinated also at the 
more substituted carbon in moderate to good efficiency (Scheme 16, 4-5m and 4-5n). 
Bicyclic ⍺-substituted aziridine 4-4o yielded trans-substituted product 4-5o with the same 
regioselectivity. 
 
Only major regioisomers are presented. Numbers are isolated yields. Numbers in parenthesis are 
regioisomeric ratio determined by 19F NMR. Reaction conditions: aziridine 1 (0.5 mmol), 65% DMPU-HF 
(98 µL, 3.6 mmol HF), DCE (1 mL), room temperature for 18 h. 
Scheme 16. Scope of N-tosylaziridines 
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Next, we tested aziridines with various N-protecting groups, see Table 13. 
Aziridines protected by Fmoc (44p), Cbz (4-4r) and benzoyl (4-4s) groups were well 
tolerated under reaction conditions, affording the corresponding β-fluoroamines 4-5p, 4-
5r and 4-5s in excellent yields and regioselectivity under standard reaction conditions. It 
should be noted that, in the reaction of 4-4s, the re-cyclized Heine product,117 which was 
the major side product in Laurent’s report110, was not observed at all under our reaction 
conditions. The acid-sensitive Boc protecting group could be well conserved by limiting 
reaction time to 20 minutes, while the yield was not reduced (Table 13, 4-5q).41 On the 
contrary, benzyl-protected aziridine 4-4t was only partially converted into 4-5t even after 
extended reaction times Table 13.  
Table 13. Scope of N-protected groups. 
 
Only major regioisomers are presented. Reaction conditions: aziridine 1 (0.5 mmol), 65% DMPU-HF (98 
µL, 3.6 mmol HF), DCE (1 mL), room temperature for 18 h, all yields are isolated yields. a) Numbers in 
parenthesis are regioisomeric ratios as determined by 19F NMR. b) Reaction was quenched after 20 minutes. 
 
 We also wanted to explore the stereochemical behavior of aziridine ring opening 
by DMPU-HF.118 Despite its importance, the absolute stereochemistry of products derived 
from the acid-catalyzed ring-opening of epoxides or aziridines have not been vigorously 
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pursued in the literature.105,108b We planned to study the stereochemistry of this reaction 
using optically pure aziridines and determine the product stereochemistry by X-ray 
crystallography. We subjected enantiomerically pure aziridine (S)-4-4d to standard 
reaction conditions, which produced (S)-4-5d with almost perfect retention of 
stereoconfiguration (Scheme 17). The retention of stereoconfiguration was further 
confirmed by the X-ray crystallography of both starting material and product (Scheme 17). 
 
Scheme 17. Stereospecific ring opening of aziridine (S)-4-4d by HF. 
The textbook mechanism for acid-catalyzed ring-opening of small ring 
heterocycles (epoxides and aziridines) is a pathway between the idealized SN2 and SN1 
mechanisms (eq-2).119 In the corresponding transition state, part of the SN1 bond-breaking 
has already happened, that is, there is significant δ+ character on the carbon being attacked 
by HF. So the regioselectivity will be determined by carbocation stability (even though a 
free carbocation does not actually form). The nucleophile (HF) will preferentially attack 
the more substituted carbon of aziridine. Because a free carbocation does not actually form, 
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the outcome of nucleophilic displacement will be exclusive inversion of configuration just 
like with an SN2 process.
119 Our regioselectivity can be well explained by this mechanism: 
the nucleophile (HF) always attacks at the more substituted carbon of aziridines (Scheme 
16). 
 
Equation 2. Mode of attack of HF on aziridine. 
This mechanism can also explain the poor results when pyridine-HF and Et3N-HF 
were used. In the case of Et3N-HF, the acidity of system is low due to the high basicity of 
Et3N, so only SN2 pathway is possible, but HF is a weak nucleophile, which led to no 
reaction at all (Table 12, entry 7). Pyridine-HF has higher acidity than Et3N-HF, but still 
has lower acidity than DMPU-HF. Due to higher acidity of DMPU-HF system, a larger 
positive charge appears at nitrogen and β-carbon of aziridine at an earlier stage of reaction 
coordinate (Equation 2). Pyridine-HF based nucleophilic substitution has more tendency 
for an SN2 attack on α-carbon of aziridines (Equation 2). This could explain why pyridine-
HF system gives a higher ratio of α-attack product (Table 12, entry 8). Of course, the steric 
factor may also influence the regioselectivity; in our case, HF is a small nucleophile, so the 
influence of steric factor is relatively small. 
For the stereochemical behavior of aziridine ring opening by DMPU-HF, in order 
to explain the experimental results (Scheme 17), we proposed a different mechanism than 
the classic mechanism: hydrogen bond-assisted SN1-like pathway. This mechanism could 
be rationalized by the fact that HF itself is a very strong hydrogen bonding donor.  
66 
 
But this mechanism failed to explain the reactions of bicyclic aziridines (Scheme 
16, 4-5j, 4-5k, 4-5e, 4-5o). In these cases, trans ring opening products were obtained, 
which indicates inversions of stereoconfiguration. We are not sure about the detailed 
mechanism yet. The inversions of stereoconfiguration maybe be explained by special 
conformation of bicyclic aziridines or the cis-products, but more research is needed.110  
4.3 Regiochemistry of products 
The relative chemical shift of 19F NMR spectroscopy is a powerful tool that can be 
easily used to probe the regioselectivity of products much more than 1H NMR 
spectroscopy.120 The wide difference in the chemical shift of the 19F NMR of regioisomers 
makes it a more reliable tool than the 1H NMR spectra in the determination of regioisomers 
for similar compounds. For example, the typical 19F NMR chemical shift for primary alkyl 
fluoride is within the range of -212 to -226 ppm and the chemical shift of the secondary 
alkyl fluoride for the same compounds have a downfield shift of about +35 ppm from their 
primary analogue, absorbing at about -177 to -191 ppm. On the other hand the difference 
in the chemical shift value of the 1H NMR for a primary alkyl fluoride and its secondary 
analogue is about 0.3 to 0.5 ppm.120 From these values, the regioselectivity of our products 
can be easily determined using the 19F NMR spectroscopy.  
Aside from comparing our data, which agrees well with literature for most of our 
compounds, the regioselectivity was reliably determined by a careful analysis of the 19F 
NMR spectroscopy. As a representative example, the 19F NMR spectrum of the crude 4-2a 




Figure 9. Representative spectrum of the regioisomeric distribution of 4-2a using 19F NMR 
 
From Figure 9 above, the regioisomeric distribution of the fluorotosyl amine can 
be easily determined. The major product (secondary alkyl fluoride) has its 19F NMR 
chemical shift at about -180 ppm and the minor product (primary alkyl fluoride) is -229 
ppm respectively. These values compare well with the data earlier discussed as well as 
what is reported in literature. More so, the ratio of the chemical shifts is an indication of 
the regioisomeric distribution of the compounds, which in this case is greater than 20:1in 






NMR spectra were recorded on AV2 400 or AV2 500 MHz Bruker spectrometers. 
Chemical shifts are given in ppm. The spectra are calibrated to the residual 1H and 13C 
signals of the solvents. Multiplicities are abbreviated as follows: singlet (s), doublet (d). 
triplet (t), quartet (q), doublet-doublet (dd), quintet (quint), septet (sept), multiplet (m), and 
broad (br).  
Materials and Methods: Unless otherwise stated, starting materials were purchased from 
Aldrich and/or Fluka. Substrates 4-1a through 4-1k were already reported in the literature. 
Solvents were purchased in HPLC quality, degassed by purging thoroughly with nitrogen 
and dried over activated molecular sieves of appropriate size. Alternatively, they were 
purged with argon and passed through alumina columns in a solvent purification system 
(Innovative Technology). Conversion was monitored by thin layer chromatography (TLC) 
using Merck TLC silica gel 60 F254. Compounds were visualized by UV-light at 254 nm 
and by dipping the plates in a polymoybdenic acid (PMA), p-anisaldehyde, 
ninhydrinsolutions or an aqueous potassium permanganate solution followed by heating 
depending on the compounds formed. Chloramine-T trihydrate (98%), 
phenyltrimethylammonium tribromide, (97%) and S-benzyltosyl aziridine (93%) were 
purchased from Sigma-Aldrich and used without further purification (unless otherwise 
stated). 





2-methylaziridine (790µL, 10mmole) was added to a biphasic mixture of EtOAc (15mL) 
and 1M k2CO3 (15mL) at 0˚C. Under vigorous stirring, the solution of 4-
methylbenzenesulfonyl chloride (1.91g, 10mmol) in EtOAc (15mL) was added dropwise. 
After 1 h the reaction was allowed to reach ambient temperature and stirred for another 12 
h. The phases were separated and the organic phase was washed with water, dried over 
Na2SO4 and concentrated. The crude white solid need no further purification and gave 98% 
yield. This compound is known107a 1H NMR (400 MHz, CDCl3) δ 7.85-7.80 (m, 2H), 7.36-
7.31 (m, 2H), 2.83 (dqd, J = 6.9, 5.6, 4.6 Hz, 1H), 2.61 (d, J = 7.0 Hz, 1H), 2.44 (s, 3H), 
2.02 (d, J = 4.6 Hz, 1H), 1.25 (d, J= 5.6 Hz, 3H) 
Aziridines 4-1b through 4-1o were made from a modified procedure by Sharpless: 
 
The product was synthesized following the method described by Jamison below 107a: 
To a mixture of Chloramine-T trihydrate (1.55 g, 5.5 mmol) and alkene (5.0 mmol) in 
CH3CN (25 mL) at ambient temperature was added PhNMe3Br3 (188.0 mg, 0.50 mmol). 
The reaction was stirred vigorously for 15 h and then concentrated in vacuo. The resulting 
residue was dissolved in CH2Cl2 (5-10 mL) and filtered through a short column (silica gel, 
3 x 4 cm) eluting with (150 mL of a 1:9 EtOAc/hexane mixture). After evaporation of the 
solvent, the residue was dissolved in CH3CN (10 mL). K2CO3 (2.77 g, 20.0 mmol) was 
added and the mixture was stirred vigorously at 45 °C for 2 h. After cooling to ambient 
temperature, the mixture was diluted with Et2O (20 mL), filtered of Celite (washing with 
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Et2O) and concentrated. The crude product was subjected to column chromatography on 
silica gel (7:1 Hex:EtOAc). 
2-Hexyl-1-tosylaziridine (4-4b) 
 
Following the general procedure starting from 1-octene (5.0 mmol, 785µL), 4-4b was 
isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 76% yield as a 
colorless gel to white solid. This compound is known.121 1H NMR (CDCl3, 400 MHz), δ 
0.85 (t, 3H, J = 6.8 Hz), 1.18-1.37 (m, 9H), 1.51-1.58 (m, 1H), 2.06 (d, 1H,J= 4.6 Hz),2.44 
(s, 3H), 2.64(d, 1H,J= 7.0 Hz), 2.66-2.71 (m, 1H), 7.33 (d, 2H,J=8.4 Hz), 7.82 (d, 2H, J= 
8.4 Hz).  
2-Phenyl-1-tosylaziridine (4-4c) 
  
Following the general procedure starting from styrene (5.0 mmol, 573µL), 4-4c was 
isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 62% yield faint 
yellow powder. This compound is known.121 1H NMR (CDCl3, 400 MHz) δ 2.38 (d, 1H, J 
= 4.6 Hz), 2.43 (s, 3H,), 2.98 (d, 1H, J = 7.3 Hz), 3.77 (dd, 1H, J = 4.6, 7.3 Hz), 7.19-7.36 





Following the general procedure starting from allylbenzene (5.0 mmol, 591µL), 4-4d was 
isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 58% yellow solid. 
This compound is known.107a 1H NMR (400 MHz, CDCl3) δ 7.71–7.66 (m,2H), 7.24–.19 
(m,2H), 7.18–7.12 (m,3H),7.07–7.02 (m,2H), 2.95(tdd,J= 7.0, 5.2, 4.6 Hz, 1H), 2.81 (dd,J= 
14.5, 5.2Hz,1H), 2.71 (d,J= 6.9 Hz, 1H),2.69 (dd,J= 14.6, 7.2 Hz,1H),2.42 (s,3H), 2.16 
(d,J= 4.5 Hz, 1H) 
2-(4-Fluorobenzyl)-1-tosylaziridine (4-4e) 
  
Following the general procedure starting from 1-allyl-4-fluorobenzene (5.0 mmol, 591µL), 
4-4e was isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 58% 
yellow solid. This compound is known.107a 1H NMR (400 MHz, CDCl3) δ 7.67–7.61 
(m,2H), 7.20 (app d, J= 8.2 Hz,2H), 7.00–6.93(m,2H), 6.82–6.76 (m ,2H), 2.92–2.82 (m, 
2H), 2.74 (d, J= 6.6 Hz, 1H), 2.56–2.48 (m, 1H), 2.43 (s, 3H), 2.16 (d, J = 4.3 Hz,1H) 
 2-(4-Chlorophenyl)-1-tosylaziridine (4-4f) 
  
Following the general procedure starting from 1-chloro-4-vinylbenzene (5.0 mmol, 
637µL), 4-4f was isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 
58% yellow solid. This compound is known.122 1H NMR (CDCl3, 400 MHz) δ 7.86 (d, 2H, 
J = 8.3 Hz), 7.34 (2H, J = 8.0 Hz), 7.26 (d, 2H, J = 8.2), 7.14 (d, 2H, J = 7.8), 3.73 (m, 1H), 





The general procedure failed in this case so an alternate procedure according to 




A solution of 1-allyl-4-methoxybenzene (50.0 mmol, 7.41 g) in CH2Cl2 (75 mL) in a 250 
mL round bottom flask was cooled to 0oC with an ice bath, m-chloroperbenzoic acid (12.1 
g, 50 mmol) was added portion wise over 10 minutes. The mixture was allowed to warm 
to ambient temperature and then stirred until TLC indicated complete consumption of the 
starting material (ca 4 h). If complete conversion is not obtained within 2 h, an additional 
portion of m-CPBA (ca 3 g) may be added and the mixture stirred an additional 2 h. After 
completion, saturated aqueous NaHCO3 (75 mL) was slowly added and the mixture was 
stirred vigorously until gas evolution had ceased, after which the mixture was poured into 
a separatory funnel. The organic layer was separated and washed with 1M aq. Sodium 
73 
 
sulfite, once with brine and then dried over Na2SO4. After removal of the solvent by rotary 
evaporation, the crude product was purified by chromatography on silica gel (hex/EtOAc 
7:1) to afford the desired product 4-4ga in 92 % as a colorless liquid. 
N-(2-Hydroxy-3-(4-methoxyphenyl)propyl)-4-methylbenzenesulfonamide (4-4gb) 
 
An oven-dried round bottom flask equipped with a magnetic stir bar was charged with 
epoxide 4-4ga (24.4 mmol, 4 g), 4-methylbenzenesulfonamide (48.8 mmol, 8.36 g), K2CO3 
(2.4 mmol, 0.337 g), BnNEt3Cl (2.4 mmol, 0.556 g), and anhydrous dioxane (5.0 mL). The 
flask was fitted with a reflux condenser and the mixture was heated to 90 °C.When 
complete consumption of the starting material was indicated by TLC after approximately 
5 hours, the mixture was cooled to ambient temperature, diluted with CH2Cl2 (30 mL) and 
then filtered through a 2 cm pad of Celite, which was thoroughly washed with CH2Cl2 (100 
mL). Purification by flash chromatography on silica gel (EtOAc/hexane, gradient, 100 to 
4:1) yielded the product 4-4gb as a white solid quantitavely. The product contains small 
amount of the TsNH2 from 
1H NMR. 
2-(4-Methoxybenzyl)-1-tosylaziridine (4-4g)  
 
To a dry 250 mL round bottom flask containing a magnetic stir bar was added 4-4gb (25 
mmol, 2.0 g) and PPh3 (29.5 mmol, 7.74 g). The flask was fitted with a rubber septum, 
purged with argon and then THF (50.0 mL) was added. The flask was cooled to 0°C with 
an ice bath and diethyl azodicarboxylate (DEAD) (29.5 mmol, 5.137 g, 4.65 mL) was 
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added drop-wise over a period of 10 minutes, after which the ice bath was removed and 
the mixture was allowed to stir at ambient temperature for 16 h. The reaction mixture was 
evaporated under reduced pressure. Et2O (200 mL) was added and the reaction was stirred 
for 20 minutes. The solids were removed by filtration through a 3cm pad of Celite, washing 
with Et2O, and the filtrate was concentrated by rotary evaporation. This crude oil so 
obtained was chromatographed on silica gel (EtOAc/hexane, gradient 20:80 to 45:55), 
which yielded the desired aziridine as a white solid 57 %. If necessary, recrystallization 
from hexanes/ethanol can also be carried out. 
1H NMR (400 MHz, CDCl3) δ 7.70 –7.66 (m, 2H), 7.25–7.19 (m, 2H), 6.98–6.92 (m, 2H), 
6.71–6.65 (m, 2H), 3.77 (s, 3H), 2.91 (tt, J = 7.1, 4.8 Hz, 1H), 2.77 (dd, J = 14.5, 5.1 Hz, 




Following the general procedure starting from  (5.0 mmol, 547 µL), 4-4h was isolated by 
column chromatography on silica gel (Hex/EtOAc, 7:1) in 84% yield as a white solid. This 
compound is known.123 1H NMR (400 MHz, CDCl3) δ = 7.81 (t, J=7.7, 2H), 7.28 (dd, 
J=17.2, 9.1, 1H), 2.98 – 2.81 (m, 2H), 2.81 – 2.52 (m, 1H), 2.41 (d, J=3.3, 1H), 1.18 (d, 





Following the general procedure starting from cyclohexene (5.0 mmol, 507 µL), 4-4i was 
isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 84% yield as a white 
solid. This compound is known.121 1H NMR (CDCl3, 400 MHz) δ 1.14-1.21 (m, 2H), 1.25-
1.47 (m, 2H), 1.79 (dt, 4H, J = 1.4, 5.8 Hz), 2.44 (s, 3H), 2.97 (t, 2H, J = 1.4 Hz), 7.32 (d, 
2H, J = 8.1 Hz), 7.81(d, 2H, J = 8.1 Hz).  
6-Tosyl-6-azabicyclo[3.1.0]hexane (4-4j) 
 
Following the general procedure starting from cyclohexene (5.0 mmol, 442 µL), 4-4j was 
isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 84% yield as a white 
solid. This compound is known.121 1HNMR (CDCl3, 400MHz) δ 7.80 (d, J =8.3Hz, 2H), 




Following the general procedure starting from cyclohex-2-enol (5.0 mmol, 491µL), 4-4k 
was isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 31% yield 
colorless oil. This compound is known.107b 1H NMR (CDCl3, 400MHz) δ 7.82 (d, J = 
8.4Hz, 2H), 7.33 (d, J = 8.1Hz, 2H), 3.93 (brs, 1H), 3.18 (m, 2H), 2.43 (s, 3H) 1.80-1.15 






Following the general procedure starting from 1-bromo-3-mthyl-2-butene (5.0 mmol, 578 
µL), 4-4l was isolated by column chromatography on silica gel (Hex/EtOAc, 7:1) in 76% 
yield as a colorless oil. 1H NMR (400 MHz, CDCl3) δ = 7.81 (d, J=8.2, 2H), 7.32 (d, J=8.0, 
2H), 3.09 (dd, J=7.0, 4.5, 1H), 2.67 (d, J=6.9, 3H), 2.41 (d, J=7.0, 1H), 2.35 (d, J=4.4, 1H), 
1.59 – 1.49 (m, 6H). 13C NMR (100 MHz, CDCl3) δ = 144.89, 134.37, 129.77, 129.69, 
128.37, 128.29, 59.75, 48.50, 31.76, 31.56, 28.85, 21.67. m/z = 318.22 ([M] +). ESI HRMS: 
calcd. for C18H22NO3S
+ ([M+H]+) 318.0158; found 318.0157. 
2-Methyl-2-(2-phenoxyethyl)-1-tosylaziridine (4-4m) 
  





To a stirred solution of 3-methyl-3-buten-1-ol (5.8mmol) in tetrahydrofuran (15 ml) were 
added sequentially phenol (0.66 g), triphenylphosphine (1.92 g) and diisopropyl 
77 
 
azodicarboxylate (1.45 g). The mixture was heated at 70° C. overnight and then was 
concentrated in vacuo. The residue was purified by column chromatography (SiO2; 
gradient: hexane/EtOAc100:0->70:30) to give (3-methyl-but-3-enyloxy)-benzene in 53 %, 
which agrees well with the literature.124 1H NMR (CDCl3, 400MHz) δ 
1H NMR (400 MHz, 
CDCl3) δ = 7.40 – 7.16 (m, 2H), 7.03 – 6.83 (m, 3H), 4.83 (dd, J=16.0, 0.7, 2H), 4.20 – 
3.97 (m, 2H), 2.51 (t, J=6.9, 2H), 1.81 (d, J=0.4, 3H). 
2-Methyl-2-(2-phenoxyethyl)-1-tosylaziridine (4-4m): Following the general procedure 
for tosyl aziridination starting from the corresponding phenoxy alkene (4-4m’, 498 mg), 4-
4m was isolated in 85% yield as a colorless liquid. 1H NMR (CDCl3, 400MHz) 
1H NMR 
(400 MHz, CDCl3) δ = 7.81 (t, J=16.3, 2H), 7.36 – 7.14 (m, 4H), 7.00 – 6.90 (m, 1H), 6.90 
– 6.79 (m, 1H), 4.13 – 3.97 (m, 2H), 2.65 (d, J=13.5, 1H), 2.45 (s, 1H), 2.41 (s, 3H), 2.29 
– 2.17 (m, 1H), 2.06 (dt, J=14.3, 5.8, 1H), 1.73 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 
158.48, 143.92, 137.75, 129.52, 129.46, 127.35, 120.84, 114.43, 77.43, 77.11, 76.79, 
64.48, 48.74, 41.38, 37.03, 21.59, 21.57, 19.12. m/z= 332.1315 ([M] +). ESI HRMS: calcd. 
for C18H22NO3S
+ ([M+H]+) 280.1338; found 332.1312 
2-Methyl-2-phenyl-1-tosylaziridine (4-4n) 
 
Following the general procedure starting with alpha-methylstyrene (5 mmol, 655 µL), the 
corresponding aziridine was isolated in 77% yield as a white solid. This compound is 
known125 (Unstable, decomposes over the bench after 24h. 1H NMR (400 MHz, CDCl3) δ 
= 9.29 – 8.98 (m, 2H), 7.86 (d, J=8.3, 2H), 7.36 (d, J=8.0, 2H), 7.33 – 7.26 (m, 3H), 2.95 






Following the general procedure starting with methylcyclohexene (5 mmol, 600 µL), the 
corresponding aziridine was isolated in 65% yield as a white solid. This compound is 
known.121 1H NMR (400 MHz, CDCl3):δ 7.81 (2H, d, J = 8.0Hz), 7.29 (2H, d, J = 8.0Hz), 
3.04 (1H, d, J = 5.6Hz), 2.41(3H, s), 2.01 – 2.07(1H, m), 1.77 – 1.86 (1H, m), 1.70(3H, s), 
1.48 – 1.59(2H, m), 1.29 – 1.44 (3H, m), 1.12 – 1.27(1H, m). 
Benzyl 2-methylaziridine-1-carboxylate (4-4p) 
 
2-Methyl aziridine is dissolved in CH2Cl2 and triethylamine under argon at 0° C. 
Benzylchloroformate is added and the contents of the flask are at room temperature 
overnight. The mixture is poured into 10% citric acid and is extracted with CHCl3. The 
organic layer is washed with dilute aqueous NaHCO3 and dried over Na2SO4. The solution 
is evaporated to yield N-Cbz-2-methyl aziridine (71% colorless oil).126 1H NMR (400 
MHz, CDCl3) δ 7.49 – 7.27 (m, 5H), 5.12 (s, 2H), 2.59 – 2.46 (m, 1H), 2.33 (d, J = 5.8 Hz, 
1H),1.99–1.92(m,1H),1.27(d,J=5.5Hz,3H). 
tert-Butyl 2-methylaziridine-1-carboxylate (4-4q) 
 
2-methylaziridine (353µL, 5mmole) was added to a biphasic mixture of dioxane (10mL) 
and 2 equivalent of NaHCO3 (252 mg) in water (10mL). Under vigorous stirring, the 
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solution of Boc anhydride (1.148µL, 5mmol) in dioxane (10mL) was added dropwise. The 
reaction was stirred for 18 h, after which the phases were separated and the organic phase 
was washed with water, dried over Na2SO4 and concentrated. The crude product was 
chromatographed on silica gel using Hexane: ethylacetate mixture (5:1) to afford the pure 
colorless oil in 89% yield. This compound is known.127 1H NMR (400 MHz; CDCl3) δ 
2.45-2.35 (m, 1H), 2.20 (d, J=5.9 Hz, 1H), 1.84 (d, J=3.7 Hz, 1H), 1.42 (s, 9H), 1.23 (d, 
J=5.9 Hz, 3H). 
(9H-Fluoren-9-yl) methyl 2-methylaziridine-1-carboxylate (4-4r) 
 
2-methylaziridine (353µL, 5mmole) was added to a biphasic mixture of EtOAc (10mL) 
and 4 equivalent of K2CO3 (2.764g) in water (10mL). Under vigorous stirring, the solution 
of fluorenylmethyloxycarbonyl chloride (1.293g, 5mmol) in EtOAc (10mL) was added 
dropwise. The reaction was stirred for 18 h, after which the phases were separated and the 
organic phase was washed with water and dried over Na2SO4, filtered and concentrated. 
The product a yellow oil (94%) needed no further purification. 
1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 7.5 Hz, 2H), 7.62 (d, J = 7.3 Hz, 2H), 7.40 (t, J 
= 7.2 Hz, 2H), 7.32 (t, J = 7.5 Hz, 2H), 4.42 (d, J = 7.0 Hz, 2H), 4.24 (t, J = 6.7 Hz, 1H), 
2.45 (s, 1H), 2.28 (d, J = 5.7 Hz, 1H), 1.95 (s, 1H), 1.57 (s, 1H), 1.27 (d, 3H). 13C NMR 
(100 MHz, CDCl3) δ 143.64, 141.32, 137.33, 127.76, 127.06, 125.08, 119.96, 67.97, 60.37, 
46.99, 33.84, 32.59, 21.04, 17.37, 14.18. : m/z= 279.13 ([M] +). ESI HRMS: calcd. for 
C18H18NO2H






2-Methyl aziridine (10mmol) is dissolved in CH2Cl2 and trimethylamine (2 equiv.) under 
argon at 0° C. Benzoylchloride (10.5mmol) is added and the contents of the flask are at 
room temperature overnight. The mixture is poured into 10% citric acid and is extracted 
with CHCl3. The organic layer is washed with dilute aqueous NaHCO3 and dried over 
Na2SO4. The solution is evaporated to yield N-Bn-2-methyl aziridine. (59 % colorless oil) 
This compound is known117 1H NMR (CDCl3, 400MHz): δ 8.03 (m, 2H), 7.55 (m, 1H), 
7.46 (m, 2H), 2.58 (m, 1H), 2.55 (d, J = 5.6 Hz, 1H), 2.15 (d, J = 3.6 Hz, 1H), 1.40 (d, J = 
5.6 Hz, 3H).  
1-Benzyl-2-methylaziridine (4-4t) 
 
2-Methyl aziridine (10mmol) is dissolved in CH2Cl2 and trimethylamine (2 equiv) under 
argon at 0° C. Benzylchloride (10.5mmol) is added and the contents of the flask are at room 
temperature overnight. The mixture is poured into 10% citric acid and is extracted with 
CHCl3. The organic layer is washed with dilute aqueous NaHCO3 and dried over Na2SO4. 
The solution is evaporated to yield N-Bn-2-methyl aziridine. (41% yellow oil). This 
compound is known128 1H NMR (CDC13) δ 1.20 (d, J = 5.4Hz, 3H), 1.37 (d, J = 6.3Hz, 
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1H), 1.49-.54(m, 1H), 1.57 (d, J = 3.6Hz, 1H), 3.39 (d, J = 13.8Hz, 1H), 3.46 (d, J = 13.5Hz, 
1H), 7.24-7.36 (m, 5H) 
General procedure for the hydrofluorination of aziridines 
In a 20 mL polyethylene vial charged with a magnetic stirrer 0.5 mmole of the aziridine is 
dissolved in 1.5 mL of dichloroethane. 98 µL of DMPU-HF (65%) was then pipetted into 
the mixture and the reaction was heated at 55 °C for 18 h. The reaction was quenched with 
NaHCO3 and the mixture was separated with DCM, washed with brine and the organic 
layer was dried over Na2SO4, concentrated under reduced pressure and chromatographed 
with silica gel using a mixture of Hexane:EtOAc (7:1) to afford the corresponding 
fluorinated product. 
 N-(2-Fluoropropyl)-4-methylbenzenesulfonamide (4-5a) 
 
The product was prepared from 2-methyl-1-tosylaziridine according to the general 
procedure to afford the title compound in 81% yield, as yellow oil. The major product was 
isolated in a 47:1 ratio as judged by 19F NMR. 1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 
7.0 Hz, 2H), 7.31 (d, J = 7.8 Hz, 2H), 4.83 (s, 1H), 4.79 – 4.56 (m, 1H), 3.35 (d, J = 1.2 
Hz, 1H), 3.29 – 2.90 (m, 1H), 2.42 (s, 3H), 1.28 (ddd, J = 24.0, 6.4, 1.1 Hz, 3H). 13C NMR 
(100 MHz, CDCl3) δ 143.61, 136.89, 129.77, 126.98, 89.15 (d, J = 167.5), 60.34, 48.14 (d, 
J = 21.3 Hz), 21.48, 20.98, 18.06 (d, J = 21.8 Hz), 14.16. 19F NMR (376 MHz, CDCl3) δ -
155.24 – -192.00 (m, 1F), -229.28 (d, J = 21.9 Hz, 1F). MS: m/z = 231.1[M] +. HRMS: 
calcd. For C10H15FNO2SH





Major isomer isolated 
This compound is known.129 The major product was prepared from the 1-octene-
tosylaziridine according to the general procedure to afford the title compound over 30:1 
ratio as determined by 19F NMR, 87%, white solid. Major isomer, 19F NMR (376 MHz, 
CDCl3, 25 °C) δ 186.3 (m, 1F) Minor 
19F NMR (376 MHz, CDCl3, 25 °C) δ 230.9 (m, 1F). 
N-(2-Fluoro-2-phenylethyl)-4-methylbenzenesulfonamide (4-5c) 
 
This compound is known.130 The product was prepared from 2-phenyl-1-tosylaziridine 
according to the general procedure to afford the title compound in 79% yield, as yellow oil 
and the only product. 1H NMR (400MHz, CDCl3) δ 7 65 (d, J = 8.0 Hz, 2H), 7.29–7.14 
(m, 7H), 5.38 (ddd, J = 48.1, 8.3, 3.4 Hz, 1H), 5.16 (dd, J = 7.8, 4.8 Hz, 1H), 3.32–3.17 (m, 
2H), 2.31 (s, 3H). 
N-(2-Fluoro-3-phenylpropyl)-4-methylbenzenesulfonamide (4-5d) 
 
This compound is known.129 The product was prepared from 2-benzyl-1-tosylaziridine 
according to the general procedure to afford the title compound in 79% yield, as a light 






The product was prepared from 2-(4-fluorobenzyl)-1-tosylaziridine according to the 
general procedure to afford the title compound in 74% yield, as a yellow solid. 
1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.11 (dd, 
J = 8.5, 5.4 Hz, 2H), 6.98 (t, J = 8.7 Hz, 2H), 4.79 – 4.69 (m, 1H), 4.62 (ddd, J = 12.6, 7.1, 
3.3 Hz, 1H), 3.29 – 3.13 (m, 1H), 3.13 – 2.98 (m, 1H), 2.98 – 2.79 (m, 2H), 2.43 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 143.78, 136.59, 130.76 (d, J = 8.0Hz) 129.84, 127.01, 
115.49 (d, J = 21.4 Hz, 92.58 (d, J = 174.1 Hz, 46.02 (d, J = 21.3 Hz), 37.64 (d, J = 21.0 
Hz) 21.53. 19F NMR (376 MHz, CDCl3) δ -103.56 – -125.42 (m, 1F), -185.09 (ddd, J = 
43.4, 31.9, 12.6 Hz, 1F). MS: m/z = 325.09 [M] +. HRMS: calcd. For C16H17F2NSO2Na
+= 
348.0840; found 348.0840, cald. For C16H18F2NSO2
+= 326.1021; found 326.1021. 
N-(2-(4-Chlorophenyl)-2-fluoroethyl)-4-methylbenzenesulfonamide (4-5f) 
 
The product was prepared from 2-(4-chlorophenyl)-1-tosylaziridine according to the 
general procedure to afford the title compound in 82% yield, as a light yellow solid. 
1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.1 Hz, 2H), 7.31 (t, J = 8.1 Hz, 4H), 7.18 (d, J 
= 8.2 Hz, 2H), 5.48 (ddd, J = 47.5, 8.1, 3.4 Hz, 1H), 4.83 (s, 1H), 3.54 – 3.01 (m, 1H), 2.43 
(s, 3H). 13C NMR (100 MHz, CDCl3) δ 143.82, 134.98, 134.92, 134.72, 129.83, 129.72, 
128.91, 128.81, 128.05, 127.13, 126.97, 126.89, 126.82, 92.06 (d, J = 174.6 Hz), 48.42 (d, 
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J = 25.0 Hz, 2H). 47.37, 21.53 19F NMR (376 MHz, CDCl3) δ -183.4 (m, 1F). MS: m/z = 
327.05 [M] +. HRMS: calcd. For C15H15ClNNaSO2Na
+= 350.0388; found 350.0390, cald. 
For C16H16ClNSO2
+= 328.0569; found 328.0571. 
N-(2-Fluoro-3-(4-methoxyphenyl)propyl)-4-methylbenzenesulfonamide (4-5g) 
 
The product was prepared from 2-(4-methoxybenzyl)-1-tosylaziridine according to the 
general procedure to afford the title compound in 82% yield, as a white solid. 1H NMR 
(400 MHz, CDCl3) δ 7.70 (d, J = 8.1 Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 7.06 (d, J = 8.5 Hz, 
2H), 6.83 (d, J = 8.5 Hz, 2H), 4.77 – 4.64 (m, 1H), 4.59 (dd, J = 6.8, 2.8 Hz, 1H), 3.79 (s, 
3H), 3.30 – 3.13 (m, 1H), 3.12 – 2.99 (m, 1H), 2.97 – 2.74 (m, 2H), 2.43 (s, 3H). 13C NMR 
(100 MHz, CDCl3) δ 143.70, 125.29, 92.82 (d, J = 173.3) 55.24, 46.06 (d, J = 21.0 H), 
37.64 (d, J = 21.0 Hz), 21.53 19F NMR (376 MHz, CDCl3) δ -170.97 – -206.82 (m, 1F). 
MS: m/z = 337.1[M] +. HRMS: calcd. For C17H20FNSO3Na
+ = 360.1040; found 360.1040, 
cald. For C17H21FNSO3
+ = 338.1221; found 337.1220. 
N-(2-Fluoropentan-3-yl)-4-methylbenzenesulfonamide (4-5h) 
 
The product was prepared from 2-ethyl-3-methyl-1-tosylaziridine according to the general 
procedure to afford mixtures of the title compound in 94% yield, as a yellow oil.1H NMR 
(400 MHz, CDCl3) δ = 7.75 (d, J=8.2, 2H), 7.28 (dd, J=14.2, 6.3, 2H), 4.86 (dd, J=17.6, 
9.3, 1H), 4.74 – 4.08 (m, 1H), 3.52 – 3.09 (m, 1H), 2.41 (s, 3H), 1.68 – 1.49 (m, 1H), 1.40 
(ddd, J=21.8, 10.7, 5.9, 1H), 1.28 – 0.98 (m, 3H), 0.96 – 0.72 (m, 3H). 13C NMR (100 
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MHz, CDCl3) δ = 143.45, 143.33, 138.25, 138.11, 129.73, 129.67, 129.60, 126.95, 126.92, 
98.06, 96.32, 92.33, 90.62, 58.96, 58.75, 52.03, 51.81, 24.77, 24.61, 24.40, 21.86, 21.81, 
21.50, 17.32, 17.13, 16.91, 14.76, 14.71, 10.15, 9.94, 9.54, 9.49. 19F NMR (376 MHz, 
CDCl3) δ = -185.12 – -188.99 (m, 1F), -193.86 – -198.22 (m, 1F) MS: m/z = 259.1[M]
 +. 
HRMS: calcd. For C12H18FNSO2Na
+ = 282.0934; found 282.093, cald. For 
C17H19FNSO2
+= 260.1115; found 260.1111. 
N-(2-Fluorocyclohexyl)-4-methylbenzenesulfonamide (4-5i) 
 
This compound is known.130 The product was prepared from the cyclohexyl-tosylaziridine 
according to the general procedure to afford the title compound, 95% yield, white solid.  
1H NMR (400 MHz, CDCl3) δ 1.13-1.29 (m, 4H), 1.32-1.52 (m, 1H), 1.71-1.76(m, 1H), 
2.04-2.15 (m, 2H),3.20-3.28 (m, 1H), 4.21 (dddd 2JH-F 50.1 Hz, 
3JH-H 9.9, 9.0, 4.5 Hz, 1H), 
4.90 (d, J)5.7Hz, 1H), 7.51-7.60 (m, 3H),7.90-7.93 (m, 2H). 
N-(2-Fluorocyclopentyl)-4-methylbenzenesulfonamide (4-5j) 
 
This compound is known.130 The product was prepared from the cyclopentyl-tosylaziridine 
according to the general procedure to afford the title compound, 83% yield, white powder.  
1H NMR (400 MHz, CDCl3) δ 1.35-1.42 (m, 1H), 1.61-2.09 (m, 5H), 2.41 (s, 3H), 3.56-
3.68 (m, 1H), 4.71(d, J) 6.1 Hz, 1H), 4.78 and 4.96 (double multiplet, 2JH-F) 51.9 Hz, 1H), 
7.32 (d, J) 7.5 Hz, 2H), 7.78 (d, J)7.6 Hz, 2H 
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N-((1S, 2R, 3R)-2-Fluoro-3-hydroxycyclohexyl)-4-methylbenzenesulfonamide (4-5k) 
 
The product was prepared from syn-7-tosyl-7-azabicyclo[4.1.0]heptan-2-ol according to 
the general procedure to afford the title compound in 61% yield, as a white solid. The 
structure of this compound is also confirmed by X-Ray crystallography. 1H NMR (400 
MHz, CDCl3) δ 7.77 (d, J = 8.3 Hz, 2H), 7.31 (d, J = 8.2 Hz, 2H), 5.08 (d, J = 5.4 Hz, 1H), 
4.57 (dtd, J = 50.0, 9.5, 4.6 Hz, 1H), 4.22 (s, 1H), 3.17 (tdd, J = 8.9, 5.6, 3.2 Hz, 1H), 2.43 
(s, 3H), 2.20 – 1.96 (m, 2H), 1.85 – 1.33 (m, 5H). 13C NMR (100 MHz, CDCl3) δ 143.63, 
136.72, 129.65, 127.21, 90.58 (d, J = 176.1 Hz,) 69.12 (d, J = 6.5 Hz), 59.68 (d, J = 18.1 
Hz), 36.44, 26.29, 21.55, 17.44 (d, J = 9.8 Hz), 14.17. 19F NMR (376 MHz, CDCl3) δ -
186.52 (d, J = 48.9 Hz, 1F). MS: m/z = 287.1 [M] +. HRMS: calcd. For C13H18FNSO3Na
+= 
310.0884; found 310.0884, cald. For C13H19FNSO3
+= 288.1064; found 288.1064. 
N-(1-Bromo-3-fluoro-3-methylbutan-2-yl)-4-methylbenzenesulfonamide (4-5l) 
 
The product was prepared from 3-(bromomethyl)-2,2-dimethyl-1-tosylaziridine according 
to the general procedure to afford the title compound in 78% yield, as a viscous colorless 
oil. 1H NMR (400 MHz, CDCl3) δ = 7.75 (d, J=8.3, 2H), 7.47 – 7.31 (m, 2H), 4.99 (dd, 
J=7.9, 4.0, 1H), 3.95 (td, J=9.7, 3.5, 1H), 3.61 (ddd, J=14.2, 8.3, 3.5, 1H), 3.18 (ddd, 
J=14.1, 9.4, 4.6, 1H), 2.43 (s, 3H), 1.46 (dd, J=21.7, 18.7, 6H). 13C NMR (100 MHz, 
CDCl3) δ = 143.83, 136.75, 129.87, 129.80, 129.67, 127.05, 96.24, 94.52, 77.34, 77.02, 
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76.70, 58.96, 58.69, 45.66, 29.68, 26.06, 25.82, 23.57, 23.33, 21.54.19F NMR (376 MHz, 
CDCl3) δ = -138.17 (dtd, J=43.4, 21.7, 10.0, 1F). MS: m/z = 337.0 [M]
 +. HRMS: calcd. 
For C12H17FBrNSO2Na
+ = 360.0040; found 360.0037, cald. For C12H18FBrNSO2
+= 
338.0220; found 338.0217. 
N-(2-Fluoro-2-methyl-4-phenoxybutyl)-4-methylbenzenesulfonamide (4-5m) 
 
The product was prepared from 2-methyl-2-(2-phenoxyethyl)-1-tosylaziridine according 
to the general procedure to afford the title compound in 93% yield, as a viscous colorless 
oil. 1H NMR (400 MHz, CDCl3) δ = 7.73 (d, J=8.2, 2H), 7.36 – 7.20 (m, 4H), 6.96 (t, 
J=7.4, 1H), 6.81 (d, J=8.6, 2H), 4.87 (t, J=6.8, 2H), 4.15 – 3.92 (m, 2H), 3.15 (ttd, J=19.9, 
13.3, 6.9, 2H), 2.41 (s, 3H), 2.17 (dqd, J=11.4, 9.0, 4.8, 2H), 1.44 (d, J=22.2, 3H). 13C 
NMR (100 MHz, CDCl3) δ = 158.09, 143.58, 136.77, 129.78, 129.51, 126.97, 121.12, 
114.34, 96.33, 94.64, 62.75, 50.48, 50.23, 36.68, 36.46, 23.17, 22.94, 21.50 19F NMR (376 
MHz, CDCl3) δ = -142.72 – -158.79 (m, 1F). MS: m/z = 351.13 [M]
 +. HRMS: calcd. For 
C18H23FNSO3
+= 352.1377; found 352.1375 
N-(2-Fluoro-2-methylcyclohexyl)-4-methylbenzenesulfonamide (4-5o) 
 
The product was prepared from 1-methyl-7-tosyl-7-azabicyclo[4.1.0]heptane according to 
the general procedure to afford the title compound in 84% yield, as a white solid. H NMR 
(400 MHz, CDCl3) δ = 7.77 (d, J=8.0, 2H), 7.27 (d, J=8.6, 2H), 5.14 (d, J=8.2, 1H), 3.45 
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– 3.20 (m, 1H), 2.41 (s, 3H), 1.95 – 1.74 (m, 1H), 1.74 – 1.51 (m, 4H), 1.43 (d, J=18.9, 
2H), 1.26 (dd, J=26.4, 12.1, 3H), 0.85 (dd, J=15.9, 9.0, 1H). 13C NMR (100 MHz, CDCl3) 
δ = 143.30, 137.71, 129.55, 127.10, 96.22, 94.49, 57.72, 35.71, 35.51, 31.55, 29.38, 22.62, 
22.01, 21.94, 21.53, 20.67, 14.09. 19F NMR (376 MHz, CDCl3) δ = -141.11. d, 1F.MS: m/z 
= 285.12 [M] +. HRMS: calcd. For C18H23FNSO3
+= 285.1272; found 285.1270. 
Benzyl (2-fluoropropyl)carbamate (4-5p) 
 
This compound is known.131 The major product (90:1 as obtained by 19F NMR) was 
prepared from benzyl 2-methylaziridine-1-carboxylate according to the general procedure 
to afford the title compound in 66% yield as a yellow. 19F NMR (376 MHz, CDCl3, 25 °C) 
δ -179.9 (m, 1F). 
tert-Butyl (2-fluoropropyl)carbamate (4-5q) 
 
This compound is known.132 The major product was prepared from tert-butyl 2-
methylaziridine-1-carboxylate (> 30:1) according to the general procedure to afford the 
title compound as a colorless oil. 19F NMR (CDCl3, 376 MHz) δ -180.8 (m, 1F). 
1HNMR 
(CDCl3, 500 MHz) δ 4.88 (br s, 1H), 4.79–4.63 (m, 1H), 3.49–3.38 (m, 1H), 3.19–3.09 (m, 
1H), 1.44 (s, 9H), 1.30 (dd, J = 23.7, 6.3 Hz, 1H). 




The product was prepared from (9H-fluoren-9-yl)methyl-2-methylaziridine-1-carboxylate 
according to the general procedure to afford the title compound quantitatively as a white 
solid 76%. The major product was isolated almost exclusively with trace amount of the 
minor product. 1H NMR (400 MHz, CDCl3) δ 7.78 (d, J = 7.5 Hz, 2H), 7.61 (d, J = 7.2 Hz, 
2H), 7.41 (t, J = 7.4 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 5.22 (brs, 1H), 4.75 (d, J = 49.3 Hz, 
1H), 4.43 (d, J = 6.7 Hz, 2H), 4.23 (t, J = 6.5 Hz, 1H), 3.66 – 3.10 (m, 1H), 1.33 (dd, J = 
23.8, 6.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 156.52, 143.87, 141.32, 127.72, 127.06, 
124.91 (d, J = 27.2 Hz), 120.01, 89.79 (d, J = 166.6 Hz), 82.40, 74.06, 66.85, 47.2, 46.19 
(d, J = 20.6 Hz), 18.05 (d, J = 21.9 Hz). Major product 19F NMR (376 MHz, CDCl3) δ -
179.71 (dddd, J = 49.1, 29.2, 24.3, 20.1 Hz, 1F), Minor product: -231.17 (d, J = 25.2 Hz, 
1F). (major:minor 57:1) MS: m/z = 299.1[M] +. HRMS: calcd. For C18H17FNSO2Na
+ = 
322.1219; found 322.1218, cald. For C18H18FNSO2
+= 300.1400; found 300.1399.  
N-(2-Fluoropropyl)benzamide (4-5s) 
 
The product was prepared from (2-methylaziridin-1-yl)(phenyl)methanone according to 
the general procedure to afford the title compound quantitatively as a yellow oil 58%. The 
major product was isolated in >30:1 regioselectivity though contaminated a little with the 
Heine product. This compound is known.132 19F NMR (CDCl3, 376 MHz) δ -168.1 (m, 1F). 
1H NMR (CDCl3, 500 MHz) δ 7.82–7.77 (m, 2H), 7.55–7.48 (m, 1H), 7.47–7.42 (m, 1H), 
6.48 (br s, 1H), 4.92–4.79 (m, 1H), 3.95–3.84 (m, 1H), 3.47–3.38 (m, 1H), 1.40 (dd, J = 

















Chromatography conditions: Waters 600 HPLC pump, Waters 2996 PDA detector, Diacel 









In conclusion, our DMPU-HF reagent usually gives high both high regioselectivity and 
high stereoselectivity in ring opening hydrofluorination of aziridines, and wide scope of β-
fluoro-amines can be accessed conveniently. These improved reaction conditions should 
have further implications on developing other ring opening reactions. 
4.5.1 Crystal data and structure refinement for (S)-4-1d. 
Identification code (S)-4-1d 
Empirical formula C16 H17 N O2 S 
Formula weight 287.37 
Temperature 100.5(6) K 
Wavelength 0.71073 Å 
Crystal system Monoclinic 
Space group P 21 
Unit cell dimensions a = 7.3082(2) Å = 90°. 
b = 12.6670(4) Å = 102.802(3)°. 
c = 7.9739(3) Å = 90°. 
Volume 719.82(4) Å3 
Z 2 
Density (calculated) 1.326 Mg/m3 
Absorption coefficient 0.225 mm-1 
F(000) 304 
Crystal color, habit colorless plate 
Crystal size 0.38 x 0.28 x 0.10 mm3 
Theta range for data collection 3.28 to 28.16°. 
Index ranges -9<=h<=9, -16<=k<=16, -10<=l<=10 
Reflections collected 17424 
Independent reflections 3518 [R(int) = 0.034] 
Completeness to theta = 28.16° 99.8 % 
Absorption correction multi-scan 
Max. and min. transmission 1.000 and 0.928 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3518 / 1 / 238 
Goodness-of-fit on F2 1.019 
Final R indices [I>2(I)] R1 = 0.025, wR2 = 0.058 
R indices (all data) R1 = 0.026, wR2 = 0.058 
Absolute structure parameter -0.03(4) 
Largest diff. peak and hole 0.291 and -0.195 e.Å-3 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for (S)-4-1d. 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
 
 X Y Z U(eq) 
S(1) 11061(1) 3397(1) 3463(1) 19(1) 
O(1) 11424(2) 2535(1) 4661(1) 29(1) 
O(2) 12605(1) 4069(1) 3308(1) 25(1) 
N(1) 9300(2) 4075(1) 3949(1) 18(1) 
C(1) 9981(2) 2935(1) 1406(2) 17(1) 
C(2) 8764(2) 2079(1) 1242(2) 21(1) 
C(3) 7874(2) 1746(1) -386(2) 22(1) 
C(4) 8166(2) 2257(1) -1853(2) 20(1) 
C(5) 9432(2) 3096(1) -1645(2) 20(1) 
C(6) 10337(2) 3445(1) -23(2) 18(1) 
C(7) 7100(2) 1951(1) -3623(2) 27(1) 
C(8) 9856(2) 5001(1) 5117(2) 22(1) 
C(9) 9055(2) 5177(1) 3275(2) 18(1) 
C(10) 7047(2) 5512(1) 2622(2) 22(1) 
C(11) 6351(2) 5249(1) 741(2) 19(1) 
C(12) 6710(2) 5936(1) -509(2) 23(1) 
C(13) 6107(2) 5702(1) -2247(2) 26(1) 
C(14) 5135(2) 4774(1) -2748(2) 26(1) 
C(15) 4775(2) 4086(1) -1510(2) 26(1) 



























































































































Symmetry transformations used to generate equivalent atoms: 
Anisotropic displacement parameters (Å2x 103) for (S)-4-1d. 
The anisotropic displacement factor exponent takes the form: -22[ h2 a*2U11 + ...   
+ 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
S(1) 19(1) 22(1) 15(1) -1(1) 3(1) 4(1) 
O(1) 37(1) 30(1) 19(1) 4(1) 5(1) 12(1) 
O(2) 17(1) 36(1) 22(1) -8(1) 2(1) -1(1) 
N(1) 21(1) 18(1) 17(1) 0(1) 6(1) 3(1) 
C(1) 18(1) 17(1) 15(1) -2(1) 4(1) 3(1) 
C(2) 22(1) 20(1) 23(1) 3(1) 10(1) -1(1) 
C(3) 19(1) 18(1) 31(1) -1(1) 9(1) -4(1) 
C(4) 16(1) 21(1) 22(1) -4(1) 4(1) 2(1) 
C(5) 23(1) 21(1) 18(1) 2(1) 6(1) -1(1) 
C(6) 19(1) 17(1) 20(1) 0(1) 6(1) -1(1) 
C(7) 24(1) 29(1) 25(1) -7(1) 1(1) -1(1) 
C(8) 25(1) 22(1) 18(1) -3(1) 5(1) 3(1) 
C(9) 20(1) 17(1) 18(1) 0(1) 4(1) 0(1) 
C(10) 22(1) 23(1) 21(1) -2(1) 5(1) 5(1) 
C(11) 13(1) 22(1) 22(1) 0(1) 4(1) 4(1) 
C(12) 18(1) 22(1) 28(1) 2(1) 4(1) 0(1) 
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C(13) 23(1) 32(1) 23(1) 8(1) 5(1) 3(1) 
C(14) 18(1) 39(1) 20(1) -2(1) -1(1) 4(1) 
C(15) 16(1) 27(1) 32(1) -7(1) 3(1) -2(1) 
C(16) 18(1) 22(1) 29(1) 3(1) 8(1) 2(1) 
 
Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2x 10 3) 
for (S)-4-1d. 
 












H(3) 7060(20) 1181(15) -490(20) 25(5) 
H(5) 9690(20) 3414(15) -2620(20) 25(4) 
H(6) 11200(20) 4013(13) 122(19) 17(4) 
H(7A) 6807 1211 -3641 40 
H(7B) 7853 2094 -4442 40 
H(7C) 5958 2351 -3916 40 
H(8A) 9110(30) 5097(14) 5910(20) 26(4) 
H(8B) 11120(20) 5105(13) 5550(20) 24(4) 
H(9) 9860(20) 5381(12) 2596(19) 11(3) 
H(10A) 6310(20) 5170(13) 3320(20) 18(4) 
H(10B) 6950(20) 6259(14) 2770(20) 23(4) 
H(12) 7330(20) 6601(14) -160(20) 27(4) 
H(13) 6340(30) 6196(16) -3120(30) 38(5) 
H(14) 4780(20) 4607(13) -3910(20) 23(4) 
H(15) 4090(30) 3439(18) -1840(20) 40(5) 















































Symmetry transformations used to generate equivalent atoms: 
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Intra-molecular Hydrogen bonds for (S)-4-1d [Å and °]. 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
 
 



















P 21 21 21 
 
Unit cell dimensions a = 8.2947(3) Å = 90°. 
 b = 9.5293(2) Å = 90°. 
 
Volume 
c = 18.8749(4) Å 
1491.92(7) Å3 
= 90°. 
Z 4  
Density (calculated) 1.368 Mg/m3  
Absorption coefficient 0.231 mm-1  
F(000) 648  
Crystal color, habit colorless prism  
Crystal size 0.30 x 0.18 x 0.15 mm3  
Theta range for data collection 3.26 to 28.06°.  
Index ranges -10<=h<=10, -12<=k<=12, -24<=l<=24 
Reflections collected 16718 
Independent reflections 3614 [R(int) = 0.046] 
Completeness to theta = 28.06° 99.8 % 
Absorption correction multi-scan 
Max. and min. transmission 1.000 and 0.845 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3614 / 0 / 248 
Goodness-of-fit on F2 1.032 
Final R indices [I>2sigma(I)] R1 = 0.0341, wR2 = 0.0733 
R indices (all data) R1 = 0.0379, wR2 = 0.0752 
Absolute structure parameter -0.04(6) 
Largest diff. peak and hole 0.376 and -0.320 e.Å-3 
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Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for (S)-4-2d. 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 
x y z U(eq) 
 
S(1) 4248(1) 5944(1) 2400(1) 17(1) 
F(1) 8675(1) 5418(1) 3467(1) 25(1) 
O(1) 4153(2) 7312(1) 2720(1) 22(1) 
O(2) 3118(2) 4889(1) 2618(1) 22(1) 
N(1) 6013(2) 5327(2) 2545(1) 19(1) 
C(1) 4047(2) 6189(2) 1476(1) 16(1) 
C(2) 3096(2) 7292(2) 1234(1) 19(1) 
C(3) 2836(3) 7433(2) 509(1) 22(1) 
C(4) 3522(2) 6500(2) 28(1) 21(1) 
C(5) 4477(2) 5416(2) 283(1) 20(1) 
C(6) 4741(2) 5248(2) 1007(1) 20(1) 
C(7) 3214(3) 6680(2) -756(1) 29(1) 
C(8) 7444(2) 6184(2) 2411(1) 19(1) 
C(9) 8236(2) 6643(2) 3092(1) 18(1) 
C(10) 9741(2) 7518(2) 2981(1) 21(1) 
C(11) 10404(2) 8068(2) 3675(1) 19(1) 
C(12) 11608(2) 7355(2) 4036(1) 22(1) 
C(13) 12140(3) 7816(2) 4694(1) 25(1) 
C(14) 11471(2) 9000(2) 4997(1) 25(1) 
C(15) 10293(2) 9737(2) 4637(1) 24(1) 





























































































































Symmetry transformations used to generate equivalent atoms: 
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Anisotropic displacement parameters (Å2x 103) for (S)-4-2d. 
The anisotropic displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...   
+ 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
S(1) 18(1) 15(1) 17(1) 0(1) 0(1) -1(1) 
F(1) 26(1) 24(1) 26(1) 8(1) -5(1) -2(1) 
O(1) 26(1) 18(1) 21(1) 0(1) 1(1) 0(1) 
O(2) 23(1) 21(1) 24(1) 1(1) 2(1) -4(1) 
N(1) 19(1) 15(1) 22(1) 0(1) -4(1) 0(1) 
C(1) 14(1) 17(1) 17(1) 1(1) -2(1) -4(1) 
C(2) 20(1) 14(1) 23(1) -1(1) 0(1) 0(1) 
C(3) 22(1) 18(1) 25(1) 4(1) -5(1) 0(1) 
C(4) 19(1) 22(1) 21(1) 2(1) -2(1) -6(1) 
C(5) 18(1) 22(1) 22(1) -6(1) 2(1) -1(1) 
C(6) 17(1) 18(1) 24(1) 0(1) -3(1) 0(1) 
C(7) 35(1) 29(1) 22(1) 1(1) -6(1) -1(1) 
C(8) 18(1) 22(1) 18(1) 2(1) 1(1) 0(1) 
C(9) 17(1) 18(1) 20(1) 2(1) 0(1) 0(1) 
C(10) 18(1) 24(1) 21(1) 3(1) 1(1) 0(1) 
C(11) 14(1) 20(1) 23(1) 4(1) 2(1) -5(1) 
C(12) 20(1) 18(1) 28(1) 4(1) 0(1) 0(1) 
C(13) 22(1) 23(1) 31(1) 8(1) -5(1) -2(1) 
C(14) 24(1) 25(1) 25(1) 2(1) -4(1) -9(1) 
C(15) 20(1) 21(1) 31(1) -3(1) 2(1) -2(1) 





Hydrogen coordinates (x 104) and isotropic displacement parameters  
(Å2x 10 3) for (S)-4-2d. 
 












H(2) 2660(20) 7920(20) 1562(10) 15(5) 
H(3) 2200(30) 8190(20) 356(10) 16(5) 
H(5) 4980(30) 4740(20) -28(12) 26(6) 
H(6) 5360(20) 4480(20) 1166(10) 19(5) 
H(7C) 4030 6193 -1020 43 
H(7A) 3241 7660 -874 43 
H(7B) 2174 6302 -873 43 
H(8A) 7130(30) 7020(20) 2157(11) 23 
H(8B) 8140(30) 5660(20) 2124(11) 23 
H(9) 7410(30) 7160(20) 3406(11) 22 
H(10A) 9440(20) 8260(20) 2682(11) 21(5) 
H(10B) 10510(30) 6930(20) 2747(11) 21(5) 
H(12) 12050(30) 6540(20) 3846(12) 32(6) 
H(13) 12980(30) 7290(20) 4911(12) 30(6) 
H(14) 11870(30) 9320(20) 5461(11) 22(5) 
H(15) 9830(30) 10510(20) 4841(12) 30(6) 











































Symmetry transformations used to generate equivalent atoms: 
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Intermolecular Hydrogen bonds for (S)-4-2d [Å and °]. 
D-H d(D-H) d(H..A) <DHA d(D..A) A 
 
N1-H1N 0.815 2.111 171.41 2.920 O1 [ -x+1, y-1/2, -z+1/2 ] 
 
 






5 OTHER NUCLEOPHILIC REACTIONS BY DMPU-HF 
5.1 Introduction 
We have successfully applied DMPU-HF to such nucleophilic fluorination as the 
hydrofluorination of alkynes,114 fluoro-Prins cyclization reaction,133 and the regioselective 
ring opening of aziridines; making it a useful if not a better addition to the HF-based 
fluorination reagents. DMPU-HF as has been established here, forms a more stable 
complex with HF in that it can handle up to 12 moles of HF per mole of DMPU in contrast 
to pyridine, which handles only 9 moles of HF per mole of pyridine. Moreover, because of 
its less basic nature, the acidic property of HF is retained in most reactions (Figure 5). 
Perhaps its non-coordinating or less nucleophilic properties make it quite useful in 
fluorination reactions utilizing metal catalysis.114 We intend to use this chapter to showcase 
some of our efforts to other applications of DMPU-HF in fluorination reactions. 
5.2 Bromofluorination of unsaturated compounds 
 Bromofluorination of alkenes involves the mixture of an electrophilic brominating 
reagent and a fluoride to form the 1,2-bromofluoro alkane. Not until recently, this reaction 
has been a major source of building blocks to many fluorine containing compounds134. 
Earlier synthetic strategies toward the synthesis of vinyl fluorides, which in turn have been 




Scheme 18. Bromofluorination of alkenes. 
The usefulness of the bromofluorination protocol has ultimately led to the 
employment of several fluorinating and brominating reagents and conditions for the 
development of this methodology.35, 134-135 Despite this fact, the challenge of obtaining 
good yield and a high regioselective product is yet to be unraveled, most especially for 
substituted allylic and/or homoallylic alkenes. For instance, Haufe and co-workers38, 134 
conducted a study of the bromofluorination of substituted allylic and the homoallylic 
alkenes (Table 14). The authors concluded that the nature of the amine/HF does not 
strongly influence the regioselectivity of bromofluorination, but influence the extent of side 
reactions like the formation of dibromides, which is usually observed with the less acidic 
Et3N.3HF. From their results, as seen in Table 14, we can see that the regioselectivity of 
the bromofluorination of terminal alkenes is essentially 2:1in most cases favoring the 
fluorine at the internal position. 
With this in mind, we decided to replicate the conditions of this reaction using N-
bromosuccinimide as the brominating source and DMPU-HF as the fluoride source 
respectively with the hope of improving the yield and regioselectivity of the 
bromofluorination especially with terminal alkenes. The results obtained from the NMR of 
the crude products showed moderate to good regioselectivity and high yields as illustrated 
in Scheme 19. 
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Scheme 19. Preliminary results of bromofluorination of alkenes with DMPU-HF. 
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Recently the development of efficient and sustainable methods for the synthesis of 
halo-fluorinated alkenes has increased due to the central role of this class of compounds in 
biological systems and pharmaceutical applications.72 Difunctionalization of carbon triple 
bonds portends an easier route to the synthesis of these group of compounds. In this project, 
we will also explore the effect of DMPU-HF and a brominating reagent on both terminal 
and internal alkynes. In our preliminary study, (Scheme 20) we found that NBS was rather 
too weak to affect the needed bromofluorination on the corresponding alkyne. However, 
the alkyne was easily converted to the corresponding bromofluoroalkene in the presence 
of DMPU-HF when it was reacted with the stronger electrophilic brominating source 1,3-
dibromo-5,5-dimethylhydantoin (DBH).  
 
Scheme 20. Bromofluorination of phenylbutyne with DMPU-HF and a brominating 
source. 
5.3 Ring opening of epoxides 
Ring opening fluorination of epoxide has been a convenient method for the 
preparation of fluorohydrin.136 Due to complications with the handling of anhydrous 
hydrogen fluoride (AHF), the direct treatment of epoxides with AHF has found limited use. 
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Alternative fluorine sources have over the years been employed in the synthesis of 
fluorohydrin. Other fluoride sources like HF-amine complex,35, 38 potassium hydrogen 
difluoride,137 silicon tetrafluoride,138 and tetrabutylammonium dihydrogen trifluoride139 
have all been applied to fluorohydrin synthesis via epoxide opening. Many of these 
methodologies suffer from limited scope and low regioselectivity. Haufe and Sattler for 
instance, systematically studied the effect of the identity of the amine and the HF/amine 
ratio on the outcome of epoxide ring-opening reactions.140 (Table 15) 
Table 15. Regioselectivity of epoxide ring opening by amine—HF reagents. 
 
The authors stated that a 70% Pyridine-HF solution provided the fluorohydrin in 
good yield and at room temperature favoring the internal fluorinated regiosiomer. Upon 
increasing the amount of pyridine in PPHF however, there was a decrease in reactivity 
providing a mixture of the internal and terminal fluorohydrins (entries 2-5, Table 15). More 
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so, the use of Et3N.3HF required forced reaction conditions and the terminal fluorohydrin 
is generated by adding external amine (entries 7-8).  
From these results we envisaged that since DMPU-HF is more acidic than 70% 
Pyridine-HF, we could obtain a more regioselective result under the same reaction 
conditions than what has been reported. So as part of our ongoing work, we tested DMPU-
HF on the ring opening of epoxides and our preliminary results are summarized in Table 
16. This project will explore a larger substrate scope that will include compounds that are 
acid and/or base sensitive and the effect of DMPU-HF on chiral epoxides will as well be 
considered. 
Table 16. Ring opening of epoxides using DMPU-HF. 
 
Though we are still exploring more substrates for the regioselective synthesis of 
fluorohydrins, our results showed good yield and good regioselectivities especially for the 
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non-symmetric epoxides. The electronic effects of compounds 5-10h and 5-10i, resulted in 
the favorability of the terminal fluorohydrin.  
5.4 Metal free dual functionalization of alkenes 
Dual functionalization of an alkene especially toward the synthesis of 1,2-
fluoroamines is a useful and novel strategy that has gained a lot of attention in the last few 
years. Compounds containing the 1,2-aminofluoro moiety are valuable as building blocks 
because they can be elaborated toward the synthesis of many medicinal drugs that have 
diverse pharmaceutical properties. 1,2-Fluoroamines are not usually obtained directly, but 
rather through multiple step protocol like the ring opening of aziridines, which usually 
proceed in anti-fashion thus forming predominantly the trans fluoroamine products. 
Though the last six years has witnessed a surge in this dual functionalization methodology 
toward aminofluorination, the use of metal catalysts and styrene substrates has limited its 
applicability.141 (Scheme 21) 
 
Scheme 21. Catalytic aminofluorination of styrenes. 
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Inspired by the work of Barry Sharpless142 in the synthesis of 1,2-aminoalcohol via 
the reaction of an alkene and chloramine-T in the presence of chromium tetraoxide. We 
investigated the effect of DMPU-HF and chloramine-T on cyclohexene and allylbenzene 
and found promising results, which when optimized will give rise to a direct procedure of 
obtaining the cis-fluoroamines from alkenes (Table 17).  
Table 17 illustrates our effort in trying to optimize the fluoroamination of alkenes 
using allyl benzene, DMPU-HF and chloramine-T. Initial studies without molecular sieves 
(MS) resulted in more of the products being converted to the fluorohydrin (entries 1 and 2) 
and no significant conversion to the fluoroamine even after prolonged reaction time. The 
addition of MS suppressed completely the formation of the fluorohydrin and gave 
promising conversion to the fluoroamine (entries 23). Several Lewis acids were added to 
boost the reaction for optimal conversion but failed to optimize the yield of the 
fluoroamine. The addition of potassium hydrogen difluoride (KHF2) resulted in moderate 
conversion to the fluoroamine (entries 13-14). We then hypothesized that a dehydrated 
chloramine-T may suppress significantly the production of the fluorohydrin (5-10e), which 
may ultimately influence the successful conversion to the fluoroamine (5-15h).  
 With the help of an Abderhalden pistol Figure 10, we obtained dry chloramine-T 




Figure 10. Abderhalden pistol 
 Gratifyingly, under the given conditions and without the aid of any additive or Lewis acid, 
the reaction proceeded smoothly to give a complete conversion to the fluoroamine (Table 
18). Interestingly, when we compared the crude NMR spectra of the cyclohexyl 
tosylfluoroamines obtained from the ring opening of aziridine and the direct dual 
functionalization of the alkene (cyclohexene), we observed a slight shift in the 19F NMR. 
That is, ca 86 ppm for the 19F of 1,2-fluorotosylamine from cyclohexyl azirdine to ca 72 
ppm for the 1,2-fluorotosylamine from the direct reaction of cyclohexene and chloramine-
T. We believed this shift may be the result of the different stereochemistry of the products 
obtained due to their different pathways of formation.  
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Table 17. Optimization studies on the direct aminofluorination of alkenes. 
 
At the time of writing this thesis, our major challenge is the isolation of the products 
obtained from this reaction. So far we have obtained the crude product cyclohexyl 
fluorotosylamine, which will help us to confirm unambiguously the stereochemistry of the 
product via X-ray crystallography and also give us plausible insights into the mechanism 
of this reaction.  
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Table 18. Fluoroamine from dry chloramine-T and DMPU-HF. 
 
5.5 Summary and conclusions 
We have shown that DMPU-HF is a useful fluorination reagent, which can 
effectively rival existing HF-based fluorination reagents. Aside from the successful 
application to the bromofluorination of alkenes, ring opening of epoxides and the dual 
fluoroamino functionalization of an alkene, the Hammond laboratory is exploring other 
useful applications of DMPU-HF. As an offshoot of this work, the Hammond laboratory is 
also exploring hydrohalogenation protocols and reagents using DMPU. 
5.6 Experimental 
General Information 
NMR spectra were recorded on AV2 400 or AV2 500 MHz Bruker spectrometers. 
Chemical shifts are given in ppm. The spectra are calibrated to the residual 1H and 13C 
signals of the solvents. Multiplicities are abbreviated as follows: singlet (s), doublet (d). 
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triplet (t), quartet (q), doublet-doublet (dd), quintet (quint), septet (sept), multiplet (m), and 
broad (br).  
Materials and Methods: Unless otherwise stated, starting materials were purchased from 
Aldrich and/or Fluka. Substrates were already reported in the literature. Solvents were 
purchased in HPLC quality, degassed by purging thoroughly with nitrogen and dried over 
activated molecular sieves of appropriate size. Alternatively, they were purged with argon 
and passed through alumina columns in a solvent purification system (Innovative 
Technology). Conversion was monitored by thin layer chromatography (TLC) using Merck 
TLC silica gel 60 F254. Compounds were visualized by UV-light at 254 nm and by dipping 
the plates in a polymoybdenic acid (PMA), p-anisaldehyde, ninhydrinsolutions or an 
aqueous potassium permanganate solution followed by heating depending on the 
compounds formed. Unless otherwise stated, starting materials were purchased from 
commercial sources. 
Synthesis and characterization of bromofluoro alkanes 
 
General method:  In a polyethylene vial charged with a magnetic stirring bar, the alkene 
(0.2 mmol) and N-bromosuccinimide (0.3 mmol) were dissolved in 0.7 mL of 
dichloromethane, then DMPU-HF (HF content 65 % wt/wt, 41 µL, 1.4 mmol) was added 
to the mixture and was stirred for 3 h at room temperature. The progress of reaction was 
monitored by TLC (green or dark brown dots on anisaldehyde stain). After completion of 
the reaction the mixture was quenched with cold water, and the organic phase was extracted 
with chloroform (5 mL). The organic phase was washed with aqueous sodium bicarbonate 
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and brine. Finally the organic phase was dried over sodium sulfate and was concentrated 
to dryness in vacuum. The crude product was chromatographed with a 10:1 mixture of 
hexanes and EtOAc to afford the corresponding bromofluoro alkanes. Unless otherwise 
stated, the crude 19F NMR data is given for unknown compounds only. 
 (3-Bromo-2-fluoropropoxy)benzene (5-2a) 
 
Yellow oil, 91% 19F NMR yield of mixture of regioisomers. This compound is 




Crude 19F NMR yield of mixture of compounds 87%. 19F NMR (376 MHz, CDCl3) 
δ -181.0 (m, 1F major), -211.2 (m, 1F minor) 
(4-Bromo-3-fluoro-3-methylbutoxy)benzene (5-2c) 
 
Dark brown oil, 84% 19F NMR yield, messy 1H spectrum 19F NMR (376 MHz, 






This compound is known134 1H NMR (400 MHz, CDCl3) δ 7.82-7.90 (m, 2H), 7.70-




Colorless oil, 89%. This compound is known51 1H NMR (400 MHz, CDCl3) δ 7.5 
(m, 5H), 5.60 (dd, J = 47.1, 7.8, 4.1 Hz, 1H), 3.66 (ddd, J = 15.3, 11.3, 7.8 Hz,1H), 3.58 
(ddd, J = 26.0, 11.3, 4.2Hz, 1H), 19F NMR (376 MHz, CDCl3) δ -175.0 (m, 1F) 
1-(2-Bromo-1-fluoroethyl)-4-chlorobenzene (5-2f) 
 
Yellow oil, 87%. This compound is known51 1H NMR (400 MHz, CDCl3) δ 7.41 
(dm, 7.3Hz, 2H), 7.32 (dm, 7.3Hz, 2H), 5.62 (ddd, J = 46.6, 7.3, 4.5 Hz, 1H), 3.68 (ddd, J 
= 16.3, 11.3, 7.3 Hz,1H), 3.61 (ddd, J = 24.4, 11.3, 4.4Hz, 1H), 19F NMR (376 MHz, 





Yellow oil, 86% (NMR). Unstable compound, decompose on silica 




Colorless oil, 82% 19F NMR yield. This compound is known 19F NMR (376 MHz, 
CDCl3) δ -170.9 (m, 1F) 
1-(3-Bromo-2-fluoropropyl)-4-fluorobenzene (5-2i) 
 






Colorless oil, 84% yield (minor unknown fluorinated product). 19F NMR (376 
MHz, CDCl3) δ -175.3 (m, 1F) 
Synthesis and characterization of fluorohydrins 
General method:  In a polyethylene vial charged with a magnetic stirring bar, the epoxide 
(0.2 mmol) was dissolved in 1 mL of dichloromethane maintained at 0 oC, then DMPU-
HF (HF content 65 % wt/wt, 41 µL, 1.4 mmol) was added slowly. The mixture was stirred 
for 1 to 2 h at this temperature and then warmed to room temperature for another 3 h. The 
progress of reaction was monitored by TLC (green or dark brown dots on anisaldehyde 
stain). After completion of the reaction, the mixture was quenched with cold water, and the 
organic phase was extracted with chloroform (5 mL). The organic phase was washed with 
aqueous sodium bicarbonate, a 2 M solution of sodium bisulfite and brine. Finally the 
organic phase was dried over sodium sulfate and was concentrated to dryness in vacuum. 
The crude product was chromatographed with a 10:1 mixture of hexanes and EtOAc to 
afford the corresponding bromofluoro alkanes. Unless otherwise stated, the crude 19F NMR 






Colorless oil, 91% NMR yield. This compound is known.143 1H NMR (400 MHz, 
CDCl3) δ 1.69-1.77 (m, 2H), 1.20-1.51 (m, 4H), 1.99-2.13 (m, 2H), 2.45 (br s, 1H), 3.57-




           Colorless oil, 94% NMR yield. This compound is known 1H NMR (400 MHz, 
CDCl3) δ 1.70-2.18 (m), 2.28 (br s, 1H), 4.42-4.44 (m, 1H), 4.91-5.03 (ddt, J = 48.4, 8.1, 
2.4 Hz, 1H) 
2-Fluorocyclooctan-1-ol (5-10c) 
 
Colorless oil, 87% NMR yield. This compound is known.144 1H NMR (400 MHz, 
CDCl3) δ 1.32-2.09 (m), 2.25 (br s, 1H), 3.78-3.89 (m, 1H), 4.46 (ddt, J = 48.6, 8.6, 2.7 





Colorless oil, 78% NMR yield. This compound is known.143 1H NMR (400 MHz, 
CDCl3) δ 2.02 (bs, 1H), 3.76-4.01 (m, 2H), 5.57 (ddd, J = 3.0, 7.5, 48.3 Hz, 1H), 7.34-7.41 
(m, 5H) 19F NMR (376 MHz, CDCl3) δ -186.8 (m) 
2-Fluoro-3-phenylpropan-1-ol (5-10e) 
 
Colorless oil, 78% NMR yield. This compound is known.143 1H NMR (400 MHz, 
CDCl3) δ 7.36-7.20 (m, 5H); 4.78 (dm, J = 49.0 Hz) 3.84-3.63 (m, 2H); 3.10-2.89 (m, 2H); 
1.92 (s, br, 1H) 19F NMR (376 MHz, CDCl3) δ: –187.6 (m). 
2-Fluoro-3-(4-fluorophenyl)propan-1-ol (5-10f) 
 
Colorless oil, 78% NMR yield. This compound is known.145 1H NMR (400 MHz, 
CDCl3) δ 2.87-3.01 (m, 2 H,) 3.63-3.83 (m, 2 H,), 4.74 (ddq, J = 48.4 Hz, 3.2 Hz and 6.0 
Hz, 1H), 6.98-7.02 (m, 2H,), 7.12-7.18 (m, 2H,); 19F NMR (376 MHz, CDCl3) δ: –116. 2 
(m, 1F), -188.3 (m, 1F) 
2-Fluoro-3-(4-methoxyphenyl)propan-1-ol (5-10g) 
 
White solid 56% NMR yield. This compound is known.145 1H NMR (400 MHz, 
CDCl3): δ 2.02 (br, 1H), 2.68-2.98 (m, 2H), 3.62-3.79 (m, 2 H), 3.81(s, 3H), 4.73(ddq, J = 
128 
 
48.8 Hz, 2.4 Hz and 6.0 Hz, 1H), 6.85 (d, J = 8.8 Hz, 2H,), 7.15 (d, J = 8.8 Hz, 2H); 19F 
NMR (376 MHz, CDCl3): δ -187.6 (m). 
3-Fluoro-2-hydroxypropyl 4-nitrobenzoate (5-10h) 
 
Brown solid, 48% yield 19F NMR (376 MHz, CDCl3) δ: –233.4 (m, 1F). 
1-(Benzyloxy)-3-fluoropropan-2-ol (5-10i) 
 
Colorless oil, 41% yield. This compound is known.146 1H NMR (400 MHz, CDCl3) 
δ 2.56 (bs, 1H), 3.54 (d, J = 5.1Hz, 2H), 3.69- 4.09 (m, 1H), 4.32 (dd, J = 48.0Hz, 2H), 4.53 
(s, 2H), 7.31(m, 5H); 19F NMR (376 MHz, CDCl3) δ: –234.85 (m, 1F) 
2-Fluorododecan-1-ol (5-10j) 
 
Waxy solid, 78% NMR yield. This compound is known.143 1H NMR (400 MHz, 
CDCl3) δ 4.524 (dm, J = 51.3 Hz, 1H); 3.77-3.50 (m, 3H); 1.71-1.16 (m, 18H); 0.85 (t, J = 
6.6 Hz, 3H) 19F NMR (376 MHz, CDCl3) δ: –189.6 (m) 
Synthesis of fluorotosyl amine via metal free protocol 
In a polyethylene vial charged with a magnetic stirring bar, the alkene (0.2 mmol), 
dry chloramine-T (1.1 equiv) was dissolved in 1 mL of dichloroethane maintained at room 
temperature. DMPU-HF (HF content 65 % wt/wt, 41 µL, 1.4 mmol) was added slowly and 
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the mixture was stirred slowly maintained at 65 oC for 18 h. The progress of reaction can 
be monitored by TLC (green or dark brown dots on anisaldehyde stain). After completion 
of the reaction the crude product was analyzed with NMR spectroscopy. The products are 












6 SPECTROSCOPIC DATA 
NMR FILES FOR MONO- AND DI-FLUORINATION OF ALKYNES 
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NMR FILES FOR PRINS-CYCLIZATION  




















































































































































































































































































































NMR FILES FOR AZIRIDINE RING OPENING 
 
























































































































































































































































































































































































































































































NMR FILES FOR AZIRIDINE BOMOFLUORINATION OF ALKENES 
 










































































































































































































NMR FILES FOR FLUOROHYDRIN SYNTHESIS 







































































































































































































































NMR FILES FOR CRUDE 1,2-FLUOROCYCLOHEXYLTOSYL AMINE 

















OE_1_Inaphtyl_pos #31-74 RT: 0.25-3.43 AV: 44 NL: 2.80E3
T: FTMS + p ESI Full ms [200.00-370.00]


































































OE_1_Br_pos #28-40 RT: 0.16-1.05 AV: 13 NL: 2.69E6
T: FTMS + p ESI Full ms [290.00-370.00]














































OE_1_Isoprop_pos #15-29 RT: 0.12-1.16 AV: 15 NL: 1.34E5
T: FTMS + p ESI Full ms [200.00-370.00]







































C14 H20 O1 F1
221.50334
222.14874
C8 H19 O2 N4 F1 224.60977223.70316 229.43221
222.95023






















OE_1_Br_pos #28-40 RT: 0.16-1.05 AV: 13 NL: 5.97E5
T: FTMS + p ESI Full ms [290.00-370.00]
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LIST OF ABBREVIATIONS USED 
AHF: Anhydrous hydrogen fluride 
CI: Chemical Ionization 
DAST: (Diethylamino)sulfur trifluoride 
DCM: Dichloromethane 
DCE: 1,2-Dichlorethane 
DMSO: Dimethylsulfonyl Oxide 
DMPU: 1,3-dimethyltetrahydropyrimidin-2(1H)-one 
DBH:1,3-dimethyl hydantoin 
dr: diastereomeric ratio 
ee: Enantiomeric excess 
EI: Electrospray Ionization 
EtOAc: Ethyl Acetate 
GC: Gas Liquid Chromatography 
h: Hour 
HBA: Hydrogen bond acceptor 
HBD: Hydrogen bond donor 
HF: Hydrogen fluoride 
HPLC: High performance liquid chromatography 







MsOH: Methanesulfonic acid 
NBS: N-Bromosuccinimide 
NMR: Nuclear magnetic resonance spectroscopy 
o: ortho 
p: para 
ppm: Parts per million 
PPHF: Pyridinium poly(hydrogen fluoride) 
Py: Pyridine 









TLC: Thin layer chromatography 
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